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ABSTRACT 
 
Natural products with their ever-growing potential applications in the drug 
discovery process have influenced many researchers to devise flexible and concise 
synthetic strategies towards these biologically active substances.  As more complex and 
structurally unique natural products are isolated from plants or microorganisms, 
developing innovative synthetic tools become highly desirable to obtain them in sufficient 
quantities.  Synthetic organic chemistry allows a thorough investigation of their biological 
properties and the endeavor enhances the dynamic evolution process of the field.  With this 
in mind, we have developed new synthetic methodologies to synthesize meroterpenoid 
paracaseolide A and an important class of 3-methylcarbazole alkaloids.  In addition, the 
same approach enabled a direct synthesis of fluorescent rosamine probes with practical 
applications. 
The first chapter of the dissertation describes the total synthesis of potential anti-
cancer agent (±)-paracaseolide A, which possesses a unique tetracyclic framework with 
concave and convex faces.  The facile synthesis of the natural product was accomplished 
in 8 steps in 6.6% overall yield, utilizing multiple sulfoxide eliminations and a key tandem 
1,4-conjugate addition/aldol reaction to introduce the necessary functional groups onto the 
tetracyclic bis-lactone scaffold.  The synthetic strategy allows diverse analogue 
development through a common advanced intermediate. 
The second chapter reveals a novel inverse electron-demand Diels–Alder (IEDDA) 
methodology to access biologically active and naturally-occurring 3-methylcarbazoles as 
xi 
 
well as synthetic derivatives using 3-chloroindoles and the 2-pyrone methyl coumalate.  
The transformation constitutes the first successful example of its kind; consequently 
extending the scope of indole dienophiles in the IEDDA reactions.  The application of the 
single-pot Diels–Alder/decarboxylation/elimination domino sequence resulted in the 
metal-free generation of carbazole alkaloids with exclusive regioselectivity in up to 90% 
yield.  
The last chapter focuses on the synthesis of rosamine probes to capitalize on a new 
strategy of an organolithium addition to a benzophenone imine-substituted xanthone.  
Subsequent acid-catalyzed deprotection and dehydration resulted in an efficient four-step 
synthesis from 3,6-dihydroxyxanthone.  The condensed synthetic approach provides rapid 
access to desirable primary amine-functionalized multifunctional rosamine analogues in 
good yields for applications in live-cell imaging.  
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CHAPTER 1. 
TOTAL SYNTHESIS OF (±)-PARACASEOLIDE A†
1.1. Introduction 
 
Natural products, mainly produced by plants and microorganisms, have played a 
vital role in providing a wide spectrum of therapeutics for the treatment and prevention of 
many diseases.1  Terpenoids are not only the largest family of natural products with 
approximately 40,000 reported structures2, but they also perhaps offer some of the most 
difficult synthetic challenges for organic chemists to overcome.3  Structurally diverse and 
rare terpenoids are continually isolated from nature; as a result, advancements in synthetic 
organic chemistry to access these biologically-active targets are desired in order to build 
an extensive structure-activity relationship database.4   
One unique subset of terpenoids that are formed through mixed biosynthetic 
pathways is called “meroterpenoids” (partial terpenoids)5 has become one of the most 
promising source of lead drug candidates in medicinal research today.6  These hybrid 
natural products contain both terpenoid and non-terpenoid components, and are mainly 
classified as polyketide–terpenoids and non-polyketide–terpenoids.7 A few prominent 
examples of the polyketide-derived meroterpenoids include pyripyropene A (1)8, the 
strongest known cholesterol-lowering natural product to date, territrem B (2)9, a  promising 
                                                          
† Adapted with permission from Guney, T.; Kraus, G. A., Org. Lett. 2013, 15, 613-615.  Copyright © 2013 
American Chemical Society. 
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lead drug candidate for the treatment of Alzheimer’s disease, and anticancer agent 
tropolactone B (3)10 as shown in Figure 1.    
 
Figure 1. Representative meroterpenoids and their biological activities. 
 
In addition, architecturally diverse non-polyketide meroterpenoids such as 
dysidavarone A (4)11, tricycloalternarene A (5)12, and paracaseolide A (6)13 similarly 
display anti-cancer activities (Figure 1).  Although these natural materials potentially offer 
great value in treating human diseases, their scarce quantities often create problems 
obtaining sufficient amounts from biological sources.  Moreover, these natural products 
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may not necessarily be the most active form of the structural framework to exhibit their 
biological activity.  Thus, they frequently require functional group modifications to achieve 
the optimal bioactivity.   
Designing a diverted total synthesis strategy14 to efficiently synthesize diverse 
natural product analogues would lead to a comprehensive bioactivity profile of the resultant 
derivatives.  Ultimately, the compilation of the bioactivity would lead to overall insights 
on the mechanism of action at the cellular level.15  Recognizing the critical need for 
synthetic campaigns to unlock the therapeutic potential of meroterpenoids, synthetic 
chemists have devised creative strategies and tactics in their total syntheses.16  Developing 
routes to some of the formidable targets prompted both the development of novel synthetic 
methods and the expansion of the chemical synthesis toolbox.  With this in mind, we 
focused our studies on crafting a novel platform strategy for the synthesis of paracaseolide 
A (6).  
Paracaseolide A (6) was isolated from the stem bark of a Chinese mangrove plant 
Sonneratia paracaseolaris by Guo and co-workers in 2011.13  Their thorough structure 
elucidation revealed a unique tetracyclic molecular architecture.  They postulated that the 
distinct tetraquinane oxa-cage bislactone system conceivably originated from a Diels– 
Alder [4+2] dimerization of an α-alkylbutenolide (Scheme 1).  
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Scheme 1. Proposed retrosynthetic pathway for paracaseolide A (6) by Guo.13   
 
The α-alkylbutenolide structural motif is expressed in a range of natural products 
that reflects the moiety’s wide range of therapeutic activities as represented in an 
antimicrobial substance ancepsenolide (9)17, an effective antitumor agent annomolon A 
(10)18, an anti-leukemic and neuroprotective terpenoid pinusolide (11)19, and an anti-
malarial agent gomphostinin (12)20 (Figure 2).  
Not surprisingly, paracaseolide A (6), the first known example of an α-
alkylbutenolide dimer, was also proven to be an active substance.  It showed significant 
inhibitory activity against dual specificity phosphates CDC25B with an IC50 value of 6.44 
µM.  Cell division cycle 25 (CDC25) phosphatases serve as key regulators of cell cycle 
progression.21  Recent studies showed the involvement of CDC25A and B in various 
human cancer lines such as breast22 and prostate23 cancer associated with tumor 
aggressiveness and poor prognosis. 
 
5 
 
 
Figure 2. Representative α-alkylbutenolides and their biological activities.  
 
Given the importance of inhibiting the cell cycle regulatory enzymes that are linked 
to carcinogenesis, many efforts have been devoted to the total synthesis of 6 and its 
potential analogues.  The Vassilikogiannakis group24 was the first to successfully tackle 
the synthetic problem.  In agreement with the initially proposed biosynthetic pathway13, 
they set out to accomplishing a Diels–Alder-dimerization of the α-alkenyl-γ-
hydroxybutenolide 8 to access the tetracyclic core of 6.  It was predicted that the concerted 
[4+2] cycloaddition would generate the diastereomer of paracaseolide A (14), which would 
be readily epimerized to 6 since having both alkyl chains on the convex face of the 
molecule would be thermodynamically more stable as shown in Scheme 2.  
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Scheme 2. Retrosynthetic analysis of paracaseolide A (6) by Vassilikogiannakis. 24 
 
 Vassilikogiannakis’s synthesis started by transforming readily available 1-
tridecanol (15) to the corresponding iodide 16, which was then lithiated and combined with 
3-furaldehyde to form furanol 17 in 96% yield.  The resulting hydroxyl group was then 
TBS protected under standard reaction conditions, furnishing silyloxyalkylfuran 18 in 84% 
yield.  [1,4] O→C silyl migration upon treatment of 18 with n-BuLi was smoothly achieved, 
producing 2-trialkylsilyl-3-(α-hydroxy)alkylfuran 19 in 96% yield.  Acid-catalyzed 
dehydration of 19 followed by methylation of the furan gave the photooxygenation 
precursor 21 in 65% yield.  Regioselective oxidation of the furan with singlet oxygen (1O2) 
was aided by the TBS group to afford 8 in 52% yield.   
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Lastly, the key step involving their hypothesized bio-inspired Diels–Alder-
dimerization/ketalization occurred under thermal conditions and in the absence of solvent 
in 59% yield, to provide 6 (Scheme 3).  In summary, the first synthetic approach described 
by Vassilikogiannakis and his colleague featured a bio-inspired cycloadditive dimerization 
strategy to form paracaseolide A in 8 steps with 15% overall yield.24   
Although this creative synthetic method efficiently provides access to the natural 
product, it still could benefit from improvements in several dimensions.  Primarily, given 
the potentially significant anti-cancer activity of the natural product, a diversity-oriented 
synthetic approach would be useful for analogue development.  Lacking the diversification 
platform, at least 7 steps to must be carried out to reach the desired α-alkenyl-γ-
hydroxybutenolide before its crucial dimerization to generate a single tetracyclic analogue 
of the natural substance.  In addition, as outlined in their manuscript, the key dimerization 
reaction required in solvent-free conditions at high temperature.  This might be another 
potential disadvantage if temperature-sensitive functional groups were incorporated on the 
skeleton of paracaseolide derivatives.  Therefore, we developed a novel diverted total 
synthesis of paracaseolide A to address the raised concerns.25  
Even though we reported the second synthesis of the aforementioned natural 
product (in a strategically different way) a few months after the appearance of the initial 
synthesis in the literature, paracaseolide A has since been attracted many synthetic groups 
around the globe.  Thus, a summary of recent reported paracaseolide A syntheses will 
preface the discussion of our unique methodology to the target.  
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Scheme 3. Synthesis of paracaseolide A (6) by Vassilikogiannakis.24  
 
In 2013, Mehta26 and his colleagues reported a very similar synthetic plan for 
paracaseolide A via the presumed biomimetic pathway described by Guo and co-workers.13  
In my view, their contribution not only shortened the number of steps to butenolide 8, but 
they also elucidated the dimerization mechanism.  In contrast to Vassilikogiannakis’s24 
proposed concerted cycloaddition mechanism which was outlined in Scheme 2, Mehta’s 
experimental results showed that the thermally-induced dimerization produced the 
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diastereomers of paracaseolide A (6 and 14) and a ring-opening by-product in a ratio of 
4.9:1:2.4 with 66% yield under essentially the same conditions as previously reported.  
Prolonging the thermal activation did not result in the interconversion of the diastereomers.  
Moreover, dimerization of an analogous butenolide 22 generated non-interconvertible 
diastereomers of tetracyclic analogues 23 and 24 in a ratio of 2:3 in 52% yield presented 
in Scheme 4.  They concluded that the dimerization route may involve a step-wise [4+2] 
mechanism, rather than a concerted one, which essentially contradicts Vassilikogiannakis’s 
observations.24  
 
 
Scheme 4.  Non-interconvertible diastereomeric paracaseolide analogues 23 and 24.26 
 
Subsequently, Stark and his co-workers27 posed an interesting hypothesis to 
investigate the possibility of an early step ketalization reaction of an α-alkenyl-γ-
hydroxybutenolide followed by a subsequent intramolecular Diels–Alder  reaction under 
Lewis acidic conditions.  On the way to test their idea, they also improved the synthesis of 
the common butenolide intermediate 8, accessing it via a 4-step sequence. As outlined in 
Scheme 5, α-angelica lactone 25 was first acyloxylated using a catalytic amount of 
palladium acetate, sodium perborate and excess acetic anhydride to yield butenolide 26.  α-
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Iodination of 26 was problematic; however, after many trials they were able to improve the 
yield of α-iodination to form 27.  Palladium-catalyzed Suzuki cross-coupling of 27 with 
vinyl boronic acid 28 provided 29, which was then hydrolyzed under basic conditions 
giving access to butenolide 8 in good yield.  Lewis acids such as Me3Al, Me2AlCl, AlCl3, 
and FeCl3 were employed but unfortunately did not promote the cycloaddition.  Only the 
Lewis acids ZnBr2 and FeBr3 exclusively gave rise to the epimer 14 in 20% and 13% yields, 
respectively.  Overall, they were able to synthesize paracaseolide A 6 in 5 steps with 25% 
yield, featuring the identical thermally-induced bio-inspired dimerization technology.     
 
 
Scheme 5. Improved synthesis of α-alkenyl-γ-hydroxybutenolide 8 by Stark.27 
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The most recent synthesis of paracaseolide A to date was described by Boukouvalas 
et al. in 2014.28  Even though their synthesis once again hinged on the pre-existent 
dimerization strategy, they uncovered a new route for the hydroxybutenolide 8 as shown 
in Scheme 6.  They planned an aldol reaction between α-angelica lactone 25 and 
tetradecanal 30 mediated by dibutylboron triflate to afford butenolide 31 as a 
diastereomeric mixture.  Crude 31 was dehydrated with the help of alumina in boiling 
pyridine to produce the dehydrobutenolide isomers 32 and 33 in 38% and 28% yield, 
respectively.  The silylation of both isomers under their newly developed conditions 
successfully generated 2-silyloxyfuran 34 in excellent yield.  The oxidation of  34 into silyl 
ketoester 35 was quantitatively occurred in the presence of dimethyldioxirane. The acid-
catalyzed ring-closing of 35 furnished hydroxybutenolide 8 which was readily dimerized 
to the final product 6. 
To date, there are a total of five reports on the total synthesis of paracaseolide A (6) 
following its isolation.  In contrast to our work25, the other four research groups utilized 
Guo’s proposal of [4+2] dimerization strategy as their key step.  Following 
Vassilikogiannakis’s 7-step butenolide 8 synthesis, other research groups became 
interested in improving the efficiency of the approach by shortening the route to the same 
butenolide building block.   
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Scheme 6. Alternate synthesis of α-alkenyl-γ-hydroxybutenolide 8 by Boukouvalas.28 
 
1.2. Results and Discussion 
 
Recognizing its great therapeutic potential and impressed by its very unusual 
structural framework, paracaseolide A (6) attracted our attention as a synthetic challenge 
shortly after its discovery published by Guo and co-workers.  After carefully analyzing the 
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three-dimensional fused ring system of the molecule, we constructed our strategy based on 
its concave and convex geometry to introduce the essential functional groups in a 
stereocontrolled fashion.   
Our first generation retrosynthetic approach to natural product 6 proposed a last-
step installation of the α,β-unsaturated lactone through a sulfoxide elimination from 
advanced intermediate 36, which would be generated via a key vicinal difunctionalization 
methodology of the α,β-unsaturated lactone 37.  Accessing substrate of the conjugate 
addition 37 was predicted through the sequential sulfenylation, oxidation, and elimination 
reactions from tetracyclic symmetrical bislactone 38.  To our advantage, the synthesis of 
38 was reported by Lin and Wu29, employing a Diels–Alder  reaction between the building 
blocks (Z)-3-hexene-2,5-dione 40 and 1,3-cylohexadiene 41 to provide the cycloaddition 
adduct 39, followed by ozonolysis and oxidation as shown in Scheme 7.  
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Scheme 7. First generation retrosynthetic analysis.  
 
Our total synthesis began with the realization of tetracyclic core 38 (Scheme 8), 
utilizing the known method developed by Wu, who made many valuable contributions in 
synthesizing novel heterocyclic cage compounds.  Diels–Alder  reaction of the cis-
enedione 40, readily prepared by oxidation30 of 2,5-dimethylfuran, and commercially 
available 1,3-cyclohexadiene 41 in a sealable tube at 100 oC in dichloromethane resulted 
in bicyclo[2.2.2]octene 39 in 75% yield.  Subjecting purified 39 to ozonolysis in 
dichloromethane at -78 oC, followed by treatment with triethylamine provided tetracylic 
hemiacetal 42 in 36% yield. Subsequent PCC oxidation then furnished tetracyclic 
bislactone 38 in 75% yield.29  
15 
 
 
Scheme 8. Synthesis of tetracyclic symmetrical bislactone 38[a].  
[a] Reagents and conditions: a) CH2Cl2, 100 oC, 24 h, 75%; b) O3, CH2Cl2, -78 oC, 40 min; then Et3N (1.0 
equiv), -78 oC to 23 oC, 3 h, 36%; c) PCC, CH2Cl2, 23 oC, 4 h, 75%. 
 
With the core structure of paracaseolide A in hand, the stage was set for the α-
functionalization of 38.  We envisaged a mono-sulfenylation followed by an oxidative 
elimination reaction to incorporate the unsaturation.  To test the feasibility of the proposed 
idea, we first considered using a more simple electrophile such as methyl iodide for α-
functionalization (Scheme 9).  Contrary to our expectations, initial attempts to generate the 
key enolate intermediate 43 was problematic. The poor solubility of 38 in ethereal solvents 
was likely the main contributing factor to the unsuccessful results obtained with LDA, 
LiTMP and t-BuOK. Alternatively, formation of enol silyl ether of 38 in the presence of 
16 
 
TMSOTf gave complex product distribution observed by 1H NMR, attributed to the 
decomposition of the silylated intermediate.  
 
 
Scheme 9. Model study towards α,β-unsaturated lactone via the enolate intermediate. 
 
Pleasingly, after screening many polar organic solvents and compatible bases, we 
found conditions to access enolate 43 using sodium hydride (1.0 equiv) and DMF at 0 oC.  
Even though the newly developed conditions were very promising, careful examination of 
the 1H NMR spectrum revealed that the obtained crude material was comprised primarily 
of the starting material 38 as shown in Scheme 10.  
The most surprising phenomenon was that in the presence of one equivalent of 
methyl iodide, the doubly methylated product 45 occurred preferentially over the desired 
singly methylated product 44.  Changing the electrophile to the more reactive allyl iodide 
did not change the trend.  The crude mixture contained starting material 38, singly allylated 
product 46, and fully allylated product 47 in a 3 : 1 : 1.5 ratio.   The unexpected preferential 
reactivity pattern uncovered through the model study led us to reevaluate our synthetic 
strategy to paracaseolide A.  Instead of spending time to optimize the reaction conditions 
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for single α-functionalization of 38, we decided to postpone the desymmetrization 
operation by one step.   
 
 
Scheme 10. Successful alkylations of 38 with sodium hydride in DMF[a,b]. 
[a] Reagents and conditions: a) NaH (1.0 equiv), MeI (1.1 equiv), DMF, 0 oC, 45 min, 38:44:45 = 26:1:23; b) 
NaH (1.0 equiv), allyl iodide (1.1 equiv), DMF, 0 oC, 45 min, 38:46:47 = 3:1:1.5. [b] Ratios determined by 
integration of crude 1H NMR.  
 
Our second generation approach entailed a final sulfoxide elimination to form the 
natural product 6, which in turn was accessed from the sulfide intermediate 48. Achieving 
subtarget 48 was envisioned via the key tandem 1,4-addition and aldol reaction from the 
α,β-unsaturated lactone 49.  Advantageously lactone 49 can potentially serve as a 
diversification platform which could be prepared through the mono-oxidation of a phenyl 
sulfide followed by elimination of the ensuing sulfoxide from the symmetrical bis-sulfide  
50.  Desired building block 50 was proposed to arise by the double-sulfenylation of the 
tetracylic core 38, as outlined in Scheme 11. 
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Scheme 11. Second generation retrosynthetic analysis. 
 
Following the restructured retrosynthesis, the first synthetic subtarget bis-sulfide 
38 was sulfenylated by the action of excess diphenyl disulfide in the presence of sodium 
hydride in DMF at 0 oC in excellent yield.  Once bis-sulfide 50 was in hand, it was ready 
for the subsequent oxidation (Scheme 12).  
Given the complexity of the substrate, we first utilized a milder oxidant, sodium 
periodate.  Standard oxidation conditions31 with this reagent only returned starting material, 
even after prolonging the reaction time. We then turned our attention to another oxidant, 
m-CPBA.  Our first trial with this reagent was successful, but the reaction conditions 
needed to be optimized since over-oxidation of a single sulfide to sulfone could have 
19 
 
prevented the ensuing elimination.  Fortunately, the single sulfide oxidation proceeded 
smoothly in the presence of one equivalent m-CPBA at room temperature, providing access 
to intermediate 51 as shown in Scheme 12.   
 
 
Scheme 12. Synthesis of α,β-unsaturated lactone 49[a]. 
[a] Reagents and conditions: a) NaH (3.0 equiv), PhSSPh (3.0 equiv), CH2Cl2, 0 oC, 3 h, 92%; b) m-CPBA 
(1.15 equiv), CH2Cl2, rt, 2 h; c) CHCl3, 75 oC, 5 min, 85%. 
 
Initially, we intended to eliminate the sulfoxide in a separate step following its 
isolation, as the literature precedent suggested that elimination traditionally occurs under 
thermal conditions between 80 oC and 120  oC.  Surprisingly, we found that the sulfoxide 
elimination was partially achieved at room temperature, observed by TLC and 1H NMR. 
After observing the tendency of the resulting sulfoxide for elimination, we aimed to 
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combine the overall transformation into a one-pot procedure.  Heating the sulfoxide after 
the workup at 75 oC for 5 min was sufficient to furnish 49 in 85% yield (Scheme 12).  
We then set out to investigate the pivotal vicinal difunctionalization32 strategy to 
construct the alkyl and alkenyl chain units of the natural product.   Since copper-promoted 
conjugate additions of hydrocarbons to α,β-unsaturated carbonyl compounds are one of the 
most well-established reactions in organic chemistry, adopting the methodology as our key 
step would be a valuable avenue for diversification of the tetracyclic scaffold 49.   
We began by studying the conjugate addition of either stoichiometric or catalytic 
organocopper reagents to the α,β-unsaturated lactone 49 before combining the addition in 
a postulated tandem process with an aldol reaction.  The viability of the key step was again 
tested on a model system.  The conjugate addition of lithium dibutylcuprate (52), readily 
prepared from n-butyllithium (2.0 equiv) and copper iodide (1.0 equiv), smoothly provided 
access to Michael (1,4) adduct 53 in 86% yield as shown in Scheme 13.  
 
 
Scheme 13. 1,4-Addition of lithium dibutylcuprate to the α,β-unsaturated lactone 49[a]. 
[a] Reagents and conditions: 49 (1.0 equiv), n-BuLi (2.4 equiv), CuI (1.2 equiv), THF, -78 oC, 1 h, 86%.  
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Although the conjugate addition of stoichiometric organocopper reagents was 
successfully demonstrated, the preparation of the requisite lithium dodecylcuprate was 
considered to be inconvenient.  Moreover, decreasing the amount of copper salt usage 
would be beneficial in terms of the scale-up potential of the reaction.   Thus, we focused 
our attention on the conjugate addition of readily available organomagnesium reagents in 
the presence of a catalytic amount of a copper salt.  Treating the lactone 49 with 
dodecylmagnesium bromide (54) and copper(I) bromide dimethyl sulfide (12 mol %) 
through normal addition resulted in a complex mixture of products.  The key to success in 
our system was the application of the inverse addition protocol as also utilized by other 
researchers.33 Thereby, the addition of dodecylmagnesim bromide to the solution of 49 and 
the copper salt gave 1,4-adduct 55 in 92% yield (Scheme 14).   
 
 
Scheme 14. 1,4-Addition of dodecylmagnesium bromide to the lactone 49[a]. 
[a] Reagents and conditions: 49 (1.0 equiv), 54 (1.3 equiv, 1.0 M in Et2O), CuBr-Me2S (12 mol%), THF, -78 
oC, 1 h, 92%.  
 
Once the optimized conditions for the conjugate addition were in place, the stage 
was set for trapping the subsequent enolate with with tetradecanal (56)34 in a tandem 
fashion. Cannulation of a freshly prepared solution of 56 into the solution of magnesium 
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enolate 57 at 0 oC yielded aldol product 58 in 72% yield as shown in Scheme 15.  The 
dehydration of 58 was not as trivial as we expected to effect the one-pot measylation-
elimination. Attempts with standard conditions employed excess triethylamine (10 equiv) 
at 0 oC followed by the addition of  mesyl chloride (5 equiv) with subsequent heating at 40 
oC in dichloromethane. The trans-olefin 48 resulted in 42% yield, along with a 
diastereomeric mixtures of mesylates.  Furthermore, the 1H NMR spectrum of the crude 
mixture indicated the presence of decomposition byproducts, which conceivably may have 
resulted from retro aldol reaction of 58 in basic media.  After several trials, we found that 
the addition of Et3N (4.0 equiv) and mesyl chloride (4.0 equiv) to the solution of 58 in 
dichloromethane at -78 oC was critically important to preclude byproduct formation.  
Prompting the elimination of the mesylates 59 by the action of DBU (4.0 equiv) at 80 oC 
in a single-pot process generated the trans olefin 48 in 65% yield.  
The final transformation of the synthesis involved the second simultaneous sulfide 
oxidation and elimination reaction.  Implementing the previously established m-CPBA 
conditions followed by the thermally induced sulfoxide elimination at 75 oC smoothly 
generated paracaseolide A (6) in 90% yield. The identity of 6 was in complete agreement 
with the isolated and synthetic natural product previously reported confirmed by the 1H 
NMR, 13C NMR, and mass spectral data.  In summary, the total synthesis of 6 was 
accomplished in 8 steps and 6.6% overall yield.   
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Scheme 15. Synthesis of paracaseolide A (6)[a].  
[a] Reagents and conditions: a) 49 (1.0 equiv), 54 (1.3 equiv, 1.0 M in Et2O), CuBr-Me2S (12 mol%), THF, -
78 oC, 1 h; b) 56 (5.0 equiv), 0 oC, 30 min, 72%; c) Et3N (4.0 equiv), MsCl (4.0 equiv), CH2Cl2, -78 oC to 23 
oC, 2 h; d) DBU (4.0 equiv), 80 oC, 8 h, 65%; e) m-CPBA (1.15 equiv), CH2Cl2, 23 oC, 2 h; f) CHCl3, 75 oC, 
5 min, 90%. 
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1.3. Conclusions 
 
Upon its isolation from the bark of a Chinese mangrove plant Sonneratia 
paracaseolaris by Guo and co-workers in 2011, paracaseolide A (6) attracted our attention 
as a structurally unique and biologically valuable target.  Our concise synthetic route to the 
natural product 6 hinged on a series of controlled sulfoxide eliminations from its tetracylic 
core framework and the key tandem 1,4-addition followed by the aldol reaction.  Designing 
the synthetic steps to take advantage of the inherent reactivity patterns as well as 
recognizing the concave and convex geometry of the molecule to control the 
stereochemistry resulted in our direct realization of the target.  Moreover, combining the 
transformations in single-pot procedures decreased the number of steps and avoided 
multiple purifications.  Potential future work to further optimize the synthesis would 
involve the steps leading to Wu’s tetracylic bislactone 38 to increase the overall yield of 6.   
Overall, in comparison to the four other synthetic approaches, all of which applied 
the same dimerization pathway to paracaseolide A, our synthesis is novel and still the only 
one that flexibly allows diverse functionalization of analogues rather than being 
specifically constrained to the target.  
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1.4. Experimental 
 
General Procedures 
All starting materials were purchased from Sigma-Aldrich; solvents were 
purchased from Fisher Scientific and used without further purification.  Sodium hydride 
(60% in mineral oil) was purchased from TCI America.  All reactions were carried out in 
flame-dried glassware under argon with dry solvents under anhydrous conditions.  All 
yields refer to chromatographically isolated products. Reactions were monitored by thin-
layer chromatography (TLC) carried out on 0.20 mm silica gel plates using UV light as a 
visualizing agent and either potassium permanganate or 5% sulfuric acid in methanol with 
heat as developing agents.  Silica gel 60Å, particle size 0.032 – 0.063 mm, was used for 
flash column chromatography.  Preparative thin-layer chromatography (PTLC) separations 
were carried out on 1.00 mm silica gel plates. 1H and 13C NMR spectra were acquired in 
CDCl3 on a Varian MR-400 or Bruker Avance III 600 MHz spectrometer.  
1H and 13C 
chemical shifts (δ) are given in ppm relative to the residual protonated chloroform peak 
(CDCl3: δH = 7.26 ppm, δC = 77.0 ppm) as an internal reference.  High-resolution mass 
spectra (HRMS) were recorded on an Agilent 6540 QTOF (quadrupole time of flight) mass 
spectrometer using ESI (electrospray ionization) or APCI (atmospheric-pressure chemical 
ionization).  Melting points are uncorrected and were analyzed on a Melt-Temp II capillary 
melting point apparatus.  
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Selected Experimental, Physical, and Spectral Data  
 
(Z)-3-hexene-2,5-dione (40).30,35  To a solution of 2,5-dimethylfuran (5.00 g, 52.0 mmol) 
in EtOH (156 mL) at room temperature was added a solution of magnesium 
monoperoxyphthalate hexahydrate (MMPP, 80%, 16.1 g, 26.0 mmol) in water (78 mL), 
dropwise via addition funnel over 10 minutes.  The resulting reaction mixture was stirred 
for 15 minutes at room temperature, monitored by TLC.  The reaction was quenched by 
NaHCO3 (sat. aq., 85 mL) and extracted with CH2Cl2 (4 x 50 mL).  No peroxide was 
detected testing the solution with potassium iodide starch paper.  The combined organic 
layers were then washed with brine (50 mL), dried over MgSO4, and concentrated in vacuo 
to afford 5 (5.77 g, 99% yield) as a yellow liquid, which was used without purification.  
40: Rf = 0.40 (silica gel, EtOAc:hexanes 1:1); 
1H NMR (CDCl3, 600 MHz) δ = 6.29 (s, 
2H), 2.29 (s, 6H) ppm; 13C NMR (CDCl3, 150 MHz) δ = 200.4 (2C), 135.7 (2C), 29.8 (2C) 
ppm. 
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Bicyclo[2.2.2]octene 39.29  To a solution of 40 (5.00 g, 44.6 mmol) in CH2Cl2 (25 mL) in 
a sealable flask was added 1,3-cyclohexadiene (4.47 g, 55.75 mmol).  After sealing the 
flask, the reaction mixture was heated to 100 oC for 24 h.  The reaction mixture was first 
cooled to room temperature then concentrated in vacuo to afford the crude product, which 
was purified by flash column chromatography (silica gel, EtOAc:hexanes 0:1 to 1:2) to 
afford 39 (6.43 g, 75% yield) as a colorless crystalline solid.  Subsequent larger scale 
reactions were conveniently purified by recrystallization from EtOAc:hexanes 1:2 and 
seeding the crude solution with pure crystals obtained from column chromatography.  8: 
m.p. 56-57 oC; Rf = 0.20 (silica gel, EtOAc:hexanes 1:1); 
1H NMR (CDCl3, 600 MHz) δ = 
6.25 (dd, J = 4.6, 3.2 Hz, 2H), 3.06 (s, 2H), 2.94 (s, 2H), 2.07 (s, 6H), 1.60–1.55 (m, 2H), 
1.37–1.30 (m, 2H) ppm; 13C NMR (CDCl3, 150 MHz) δ = 207.7 (2C), 132.3 (2C), 56.6 
(2C), 32.5 (2C), 29.6 (2C), 25.0 (2C) ppm. 
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Oxa-cage tetraquinane 42.29  To a solution of 39 (5.00 g, 26.0 mmol) in CH2Cl2 (200 mL) 
was bubbled O3 at -78 
oC.  The solution turned blue in color after approximately 40 minutes 
after which Et3N (2.63 g, 26.0 mmol) was added dropwise.  The reaction mixture was 
slowly warmed to room temperature and stirred for an additional 3 hours.  The reaction 
mixture was concentrated in vacuo and purified by flash chromatography (silica gel, 
EtOAc:hexanes 1:1 to 3:1) to afford 42 (2.25 g, 36% yield) as a white solid.  42:  Rf = 0.20 
(silica gel, EtOAc:hexanes 3:1); 1H NMR (CDCl3, 600 MHz) δ = 5.21 (d, J = 4.4 Hz, 1H), 
3.11 (s, 1H), 3.09–3.04 (m, 1H), 2.99 (t, J = 10.9 Hz, 1H), 2.77 (t, J = 10.9 Hz, 1H), 2.45–
2.37 (m, 1H), 2.15–2.08 (m, 1H), 1.91–1.82 (m, 1H), 1.66 (s, 3H), 1.63 (s, 3H), 1.61–1.54 
(m, 2H), 1.47–1.38 (m, 1H) ppm; 13C NMR (CDCl3, 150 MHz) δ = 176.7, 119.3, 116.1, 
104.4, 44.8, 44.7, 41.8, 38.4, 27.3, 25.9, 19.7, 19.2 ppm.  
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Bis-lactone 38.29  To a solution of 42 (2.00 g, 8.32 mmol) in CH2Cl2 (120 mL) was added 
Celite (12.6 g) and pyridinium chlorochromate (3.59 g, 16.6 mmol) sequentially and the 
reaction mixture was stirred at room temperature for 4 hours.  The reaction mixture was 
filtered through Celite, concentrated in vacuo, and purified by flash chromatography (silica 
gel, EtOAc:hexanes 1:1 to 3:1) to afford 38 (1.48 g, 75% yield) as a slightly brown-white 
solid. 38: Rf = 0.10 (silica gel, EtOAc:hexanes 3:1); 
1H NMR (CDCl3, 400 MHz) δ = 3.11 
(s, 2H), 3.05–2.94 (m, 2H), 2.16–2.00 (m, 2H), 1.92–1.76 (m, 2H), 1.70 (s, 6H). ppm; 13C 
NMR (CDCl3, 150 MHz) δ = 175.1 (2C), 116.4 (2C), 43.6 (2C), 37.2 (2C), 24.8 (2C), 18.0 
(2C) ppm. 
 
 
Bis-sulfide 50.  To a suspension of NaH (0.17 g, 7.10 mmol) in DMF (4 mL) at 0 oC was 
added a solution of 38 (0.54 g, 2.27 mmol) in DMF (4 mL) dropwise over 5 minutes which 
was stirred for an additional 5 minutes.  Diphenyl disulfide (1.55 g, 7.10 mmol) in DMF 
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(4 mL) was brought to 0 oC and added dropwise over 5 minutes to the sodium hydride 
solution.  The resulting reaction mixture was stirred for 3 h at 0 oC, monitored by TLC. 
The reaction was quenched by ice-cold water (10 mL) and partitioned between EtOAc (100 
mL).  The organic layer was washed with water (4 x 40 mL) and brine (40 mL), dried over 
MgSO4, and concentrated in vacuo.  The crude product was purified by flash column 
chromatography (silica gel, EtOAc:hexanes 0:1 to 2:1) to afford 50 (0.95 g, 92% yield) as 
a white crystalline solid.  50: m.p. 193-195 oC; Rf = 0.90 (silica gel, EtOAc:hexanes 3:1); 
1H NMR (CDCl3, 600 MHz) δ = 7.57 (d, J = 7.1 Hz, 4H), 7.48 (t, J = 7.5 Hz, 2H), 7.40 (t, 
J = 7.6 Hz, 4H), 3.08 (s, 2H), 2.10–2.01 (m, 2H), 1.89–1.81 (m, 2H), 1.38 (s, 6H) ppm; 13C 
NMR (CDCl3, 150 MHz) δ = 173.5 (2C), 137.5 (4C), 130.9 (2C), 129.4 (4C), 128.7 (2C), 
114.3 (2C), 53.1 (2C), 51.5 (2C), 28.1 (2C), 25.9 (2C) ppm; HRMS (APCI-TOF) calcd for 
C24H23O5S2 [M + H]
+ 455.0981, found 455.0982. 
 
 
α,β-Unsaturated lactone 49.  To a solution of bis-sulfide 50 (0.70 g, 1.54 mmol) in CH2Cl2 
(60 mL) at room temperature was added a solution of m-CPBA (77%, 0.33 g, 1.77 mmol) 
in CH2Cl2 (60 mL), dropwise over 15 minutes.  The reaction was monitored by TLC and 
after 2 h, the reaction was quenched by NaHCO3 (sat. aq., 50 mL).  The combined organic 
phases were washed with water (2 x 30 mL) and brine (30 mL), dried over MgSO4, and 
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concentrated in vacuo.  To complete the elimination of any remaining sulfoxide, anhydrous 
CHCl3 (50 mL) was added and the heating bath on the rotary evaporator was maintained 
at 75 oC as the CHCl3 slowly evaporated without vacuum for 5 minutes.  The remaining 
CHCl3 was concentrated in vacuo.  The crude product was purified by flash column 
chromatography (silica gel, EtOAc:hexanes 1:2) to afford 49 (0.45 g, 85% yield) as a white 
crystalline solid.  49: m.p. 145-146 oC; Rf = 0.50 (silica gel, EtOAc:hexanes 2:1); 
1H NMR 
(CDCl3, 400 MHz) δ = 7.57 (d, J = 6.9 Hz, 2H), 7.50 (t, J = 7.4 Hz, 1H), 7.41 (t, J = 7.4 
Hz, 2H), 6.96 (dt, J = 7.8, 3.5 Hz, 1H), 3.33 (dt, J = 9.7, 2.8 Hz, 1H), 3.28 (d, J = 9.7 Hz, 
1H), 2.92 (dd, J = 15.0, 7.9 Hz, 1H), 2.36 (ddd, J = 15.1, 3.7, 2.5 Hz, 1H), 1.77 (s, 3H), 
1.74 (s, 3H) ppm; 13C NMR (CDCl3, 150 MHz) δ = 172.2, 165.3, 137.8, 137.6 (2C), 131.51, 
130.9, 129.3 (2C), 127.7, 114.5, 113.2, 56.2, 53.7, 47.3, 33.5, 26.9, 25.4 ppm; HRMS 
(APCI-TOF) calcd for C18H17O5S [M + H]
+ 345.0791, found 345.0792. 
 
 
Alcohol 58.  To a cloudy, pale yellow solution of α,β-unsaturated lactone 49 (250 mg, 0.73 
mmol) and CuBr-Me2S (24 mg, 0.11 mmol) in THF (25 mL) at -78 
oC was added dodecyl 
magnesium bromide (1.0 M in Et2O, 0.95 mL, 0.95 mmol) dropwise over 5 min, after 
which the solution became bright yellow-green in color.  After 30 min, a TLC analysis 
showed complete consumption of starting material and formation of the 1,4-adduct.  At 
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that time, the -78 oC bath was replaced by an ice bath and stirred for an additional 5 min. 
To the reaction mixture, an ice-cold solution of freshly prepared anhydrous tetradecanal34 
(775 mg, 3.65 mmol) in THF (10 mL) was transferred by cannula over 5 min, during which 
the reaction mixture changed from a cloudy yellow to a clear, pale yellow solution. 
Complete consumption of the 1,4-enolate intermediate and formation of the tandem aldol 
product as a single diastereomer was observed by TLC after 15-20 minutes.  The reaction 
was quenched by slowly adding cold NH4Cl solution (sat. aq., 10 mL) at 0 
oC, during which 
time the solution became blue in color.  The reaction mixture was poured into a separatory 
funnel, diluted with CH2Cl2 (200 mL) and washed with water (2 x 50 mL) and brine (50 
mL).  The combined organic layers were dried over MgSO4 and concentrated in vacuo with 
a water bath temperature maintained at 35 oC.  The crude product was purified by flash 
column chromatography (silica gel, EtOAc:hexanes 1:9 to 1:2) to afford 58 (380 mg, 72% 
yield) as a colorless oil.  58: Rf = 0.80 (silica gel, EtOAc:hexanes 2:1); 
1H NMR (CDCl3, 
400 MHz) δ = 7.56 (d, J = 7.2 Hz, 2H), 7.47 (t, J = 7.3 Hz, 1H), 7.40 (t, J = 7.3 Hz, 2H), 
4.17 (dd, J = 10.3, 3.0 Hz, 1H), 3.18 (d, J = 12.1 Hz, 1H), 3.11 (d, J = 12.6 Hz, 1H), 2.23–
2.09 (m, 2H), 2.05 (d, J = 4.6 Hz, 1H), 1.69 (s, 3H), 1.65 (s, 3H), 1.44–1.13 (m, 46H), 0.88 
(t, J = 6.8 Hz, 6H) ppm; 13C NMR (CDCl3, 150 MHz) δ = 177.9, 172.9, 137.4 (2C), 130.6, 
129.2 (2C), 128.7, 115.9, 115.1, 72.2, 55.0, 54.8, 51.5, 45.9, 38.2, 33.7, 32.4, 31.9 (2C), 
29.6 (9C), 29.6, 29.4 (2C), 29.4 (4C), 28.3, 27.4, 26.8, 26.5, 25.6, 22.7 (2C), 14.1 (2C) 
ppm; HRMS (APCI-TOF) calcd for C44H71O6S [M + H]
+ 727.4966, found 727.4971. 
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Trans olefin 48.  To a solution of 58 (250 mg, 0.34 mmol) in CH2Cl2 (8 mL) in a sealable 
tube at -78 oC was added Et3N (0.19 mL, 1.36 mmol) and MsCl (0.11 mL, 1.36 mmol) 
sequentially and the reaction mixture was slowly warmed to room temperature and stirred 
for 2 h.  DBU (0.20 mL, 1.36 mmol) was added and the reaction mixture was heated to 80 
oC for 8 h, after which the reaction was cooled to room temperature, diluted with CH2Cl2 
(50 mL), quenched with NH4Cl (sat. aq., 15 mL), and washed with water (2 x 30 mL) and 
brine (30 mL).  The combined organic layers were dried over MgSO4 and concentrated in 
vacuo.  The crude product was purified by flash column chromatography (silica gel, 
EtOAc:hexanes 0:1 to 1:4) to afford 48 (160 mg, 65% yield) as a colorless oil.  48: Rf = 
0.60 (silica gel, EtOAc:hexanes 1:4); 1H NMR (CDCl3, 400 MHz) δ = 7.58 (d, J = 7.1 Hz, 
2H), 7.47 (t, J = 7.4 Hz, 1H), 7.39 (t, J = 7.5 Hz, 2H), 5.75 (dt, J = 15.4, 6.8 Hz, 1H), 5.47 
(d, J = 15.8 Hz, 1H), 3.10 (d, J = 11.7 Hz, 1H), 3.03 (d, J = 11.7 Hz, 1H), 2.17–2.00 (m, 
4H), 1.99–1.93 (m, 1H), 1.60 (s, 3H), 1.36–1.22 (m, 42H + 3H), 0.88 (t, J = 6.2 Hz, 6H) 
ppm; 13C NMR (CDCl3, 100 MHz) δ = 174.8, 174.4, 137.4 (2C), 134.6, 130.9, 129.5 (2C), 
129.3, 128.2, 115.0, 114.8, 53.9, 51.7, 51.2, 49.8, 39.3, 32.6, 31.9 (2C), 29.8, 29.6 (8C), 
29.5 (2C), 29.4 (3C) 29.2, 29.0, 27.7, 27.4, 25.5, 25.3, 22.7 (2C), 14.1 (2C) ppm; HRMS 
(ESI-TOF) calcd for C44H69O5S [M + H]
+ 709.4859, found 709.4841. 
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Paracaseolide A (6).  To a solution of 48 (66 mg, 0.093 mmol) in CH2Cl2 (4 mL) at room 
temperature was added a solution of m-CPBA (77%, 17 mg, 0.10 mmol) in CH2Cl2 (3 mL), 
dropwise over 5 minutes. The reaction was monitored by TLC and after 2 h, the reaction 
was quenched by NaHCO3 (sat. aq., 5 mL) and diluted with CH2Cl2 (5 mL).  The combined 
organic phases were washed with water (2 x 5 mL) and brine (5 mL), dried over MgSO4, 
and concentrated in vacuo.  To complete the elimination of any remaining sulfoxide, 
anhydrous CHCl3 (10 mL) was added and the heating bath on the rotary evaporator was 
maintained at 75 oC as the CHCl3 slowly evaporated without vacuum for 5 minutes.  The 
remaining CHCl3 was concentrated in vacuo.  The crude product was purified by 
preparative TLC (silica gel, EtOAc:hexanes 1:4) to afford 6 as a white crystalline solid (50 
mg, 90% yield). 6: Rf = 0.40 (silica gel, EtOAc:hexanes 1:4); 
1H NMR (CDCl3, 400 MHz) 
δ = 7.24 (dd, J = 7.4, 3.0 Hz, 1H), 5.83 (dt, J = 14.5, 6.8 Hz, 1H), 5.49 (d, J = 15.9 Hz, 
1H), 3.36 (dd, J = 9.5, 2.9 Hz, 1H), 3.30 (d, J = 9.6 Hz, 1H), 3.04 (ddd, J = 11.6, 7.7, 3.5 
Hz, 1H), 2.14–2.09 (m, 2H), 1.76 (s, 3H), 1.72–1.65 (m, 1H), 1.62 (s, 3H), 1.48–1.03 (m, 
41H), 0.88 (t, J = 6.6 Hz, 6H) ppm; 13C NMR (CDCl3, 100 MHz) δ =175.0, 166.2, 144.7, 
135.1, 129.3, 126.2, 115.4, 113.8, 58.3, 50.2, 46.7, 45.0, 32.7, 31.9 (2C), 29.6 (8C), 29.5, 
29.4 (2C), 29.3 (2C), 29.1, 29.0, 28.2, 28.0, 26.6, 25.7, 22.7 (2C), 14.1 (2C) ppm; HRMS 
(ESI-TOF) calcd for C38H63O5 [M + H]
+ 599.467, found 599.4669. 
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CHAPTER 2. 
FIRST DIELS–ALDER STRATEGY OF INDOLES AND METHYL 
COUMALATE TO CARBAZOLE ALKALOIDS† 
 
2.1. Introduction 
 
Cycloaddition reactions1 have become one of the most powerful synthetic tools for 
the synthesis of complex polycyclic molecules as they often provide numerous advantages 
in controlling the desired chemo-, regio-, diastereo-, and enantioselectivity.  Among the 
top versatile cycloaddition technologies includes the [4+2]-cycloaddition or the Diels–
Alder reaction2, which has been successfully applied as a key step in the construction of 
the bicyclic moieties of natural products and biologically active substances, ever since its 
discovery by Otto Diels and Kurt Alder in 1928.3  Moreover, because of its efficiency at 
forming two new σ bonds by the reorganization of the π-electron system, the Diels–Alder 
reaction has been showcased as an ideal synthetic method in the context of atom economy 
advanced by Trost.4  
Based on the electronic properties of the substituents present on the diene and the 
dieophile, Diels–Alder reactions can be categorized into two main groups: 
(i) The normal electron-demand Diels–Alder reaction 
(ii) The inverse electron-demand Diels–Alder (IEDDA) reaction 
                                                          
† Adapted with permission from Guney, T.; Lee, J. J.; Kraus, G. A., Org. Lett. 2014, 16, 1124-1127.  
Copyright © 2014 American Chemical Society. 
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Contrary to the normal electron-demand Diels–Alder reaction, the IEDDA reaction takes 
place between electron-poor dienes and electron-rich dienophiles, as first demonstrated in 
1959 by Carboni and co-workers5 between 3,6-bis-(polyfluoroalkyl)-1,2,4,5-tetrazines as 
electron-poor dienes and various olefins as electron-rich dienophiles to form pyridazines. 
As discoveries of structurally diverse alkaloids containing the indole moiety 
appeared, efficient methodologies featuring indole chemistry have since been generated.  
Given its potential tunability through electron-rich or electron-withdrawing substituents, 
utilizing the 2,3-carbon–carbon double bond of the indole offered advantages when applied 
to cycloaddition reactions.  In this regard, the [4+2]-cycloaddition has been one of the most 
appealing pericyclic concepts for the indole building blocks.6  The enamine substructure 
of the indole has served in both normal electron-demand Diels–Alder and IEDDA reactions 
as the dienophile for the assembly of heterocyclic natural products.  Some of the most 
notable and successful cycloaddition methodologies were discovered after the first IEDDA 
reaction of indoles pioneered independently by both Seitz7 and Takahashi8 in 1976 
employing 1,2,4,5-tetrazines. 
In his studies, Seitz reported that 1-methylindole (1) underwent a [4+2] 
cycloaddition with methyl 1,2,4,5-tetrazine-3,6-dicarboxylate (2) followed by release of 
nitrogen to produce cycloadduct 3.  Rapid rearrangement of intermediate 3 via the ring-
opening of the pyrrole component and its subsequent amidation resulted in 
pyridazinoquinolone 5 in 45% yield as shown in Scheme 1.  
Similarly, Takahashi and co-workers revealed that refluxing the solution of indole 
(6) and 3,6-di-(2-pyridyl)-1,2,4,5-tetrazine (7) in toluene gave 5H-pyridazino[4,5-b]indole 
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8 in 35% yield as shown in Scheme 2.  They described this as an unexpected result since 
the cycloadduct intermediate further aromatized to 8, which was not observed by Seitz in 
his analogous system. The initial success obtained with 1,2,4,5-tetrazines was then 
expanded to other azadienes such as 1,2,4-triazines and 1,2-diazines (pyridazines).  More 
examples are comprehensively provided in the recent reviews by Snyder9 and Berthel.10  
 
 
Scheme 1. Reaction of 1-methylindole (1) and tetrazine 2 to obtain quinolone 5 by Seitz.7  
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Scheme 2. Reaction of indole (6) and tetrazine 7 to form pyridazinoindole 8 by Takahashi.8 
 
 Several years later, another breakthrough in [4+2]-cycloaddition reactions of 
indoles was achieved by our group.  Kraus and co-workers11 demonstrated the first example 
of an intramolecular Diels–Alder reaction using an indole as the dienophile, where highly 
functionalized dihydroindoles were prepared in the presence of amide or urea tethered 
dienes attached to the indole moiety.  For example, methyl indole-3-carboxylate and the 
diene acid were coupled to afford amide 9, which was then subjected to thermal conditions 
to furnish dihydroindole 10 in 93% yield as shown in Scheme 3.   
 
 
Scheme 3. Synthesis of dihydroindoles via intramolecular Diels–Alder strategy by Kraus.11 
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Additionally, Stoltz and co-workers12 described a novel route to the indoline 
alkaloid communesin B based on a key IEDDA reaction between the indole derivative 11 
and an o-azaxylylene generated in situ from chloroaniline 12 through base-induced 
hydrogen chloride elimination developed by Corey.13  The cycloaddition reaction took 
place smoothly at -78 oC to give the adduct 13 in 99% yield as a 1:1 diastereomeric mixture 
as shown in Scheme 4.  The cycloadduct 13 was then further advanced to a potential 
intermediate for communesin B.   
 
 
Scheme 4. Synthesis of pentacylic potential communesin B precursor by Stoltz.12 
 
 More recently, three very innovative strategies for the construction of the 
polycyclic core of strychnine (14) were designed by the Bodwell14, Padwa15, and 
Vanderwal16 labs.  Although each group envisioned strategically different sets of functional 
group manipulations to obtain the natural product, they all had a common [4+2]-
cycloaddition key step.   
Padwa chose an intramolecular Diels–Alder approach.  The tetracyclic intermediate 
15 was achieved in 95% yield when furanylindole 16 was subjected to thermal conditions 
in a microwave reactor in the presence of catalytic magnesium iodide.  Subsequent 
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transformations of the tetracycle 15 afforded the natural alkaloid, strychnine (14) as shown 
in Scheme 5.15  
On the other hand, Bodwell focused on an IEDDA route utilizing the cyclophane 
17 which was rapidly accessed from tryptamine.  Inducing the cycloaddition of 17 by heat 
provided the pentacyclic product 18 in quantitative yield.  Stereospecific installation of the 
key quaternary stereogenic center was an attractive feature of Bodwell’s synthesis.14   
 Most recently, Vanderwal’s group disclosed their elegant work on the total 
synthesis of strychnine (14) in six linear steps, the shortest route to date.  Their assembly 
of the core framework featured a pivotal IEDDA reaction of tryptamine-derived Zincke 
aldehyde 19 under base-mediated conditions. They were able to form the tetracyclic moiety 
20 in 64% yield.16   
As witnessed by the short literature review described herein, the Diels–Alder 
reaction has been the subject of stimulating research in the field of synthetic organic 
chemistry.  The flexibility of the indole 2,3-carbon–carbon double bond in either normal 
electron-demand Diels–Alder or IEDDA reactions has been encountered on numerous 
occasions.  In particular, the three highlighted routes to strychnine impressively displayed 
the exceptional tunability of the indole in [4+2]-cycloaddition reactions in the formation 
of complex targets.   
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Scheme 5. [4+2]-cycloaddition strategies to the complex natural alkaloid strychnine (14). 
 
The scope of the IEDDA reaction in the context of indoles as dienophiles has been 
limited to electron-deficient heteroaromatic azadienes such as 1,2,4,5-tetrazines, 1,2,4-
triazines and 1,2-diazines.9,10  Furthermore, 2-nitrovinyl-substituted quinones17, o-
azaquinones18, and aza-ortho-xylylenes19 have been successful.  However, the restricted 
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scope of the indoles in the IEDDA reaction can be attributed to the greater challenge of 
breaking its aromaticity compared to enamines.  The nucleophilicity of the 3-position can 
additionally hinder the desired IEDDA reaction, which has led researchers to apply an 
intramolecular approach to circumvent the issues.   
One noticeable obstacle for the indole Diels–Alder reactions has been electron-
deficient pyrones. Although pyrones have been very effective in many [4+2]-
cycloadditions20, Snyder’s early work recognized that methyl coumalate (21) was 
unreactive towards substituted indoles under his reaction conditions.21  He discovered that 
the pyrones instead underwent nucleophilic additions to generate 3-substituted indole 
adducts. 
The intriguing question of whether an IEDDA reaction can be accomplished 
between an indole and a pyrone empowered our research to invent a new methodology to 
naturally-occurring carbazole alkaloids (22).  Our research group has been investigating 
green platform technologies to access a diverse array of functionalized aromatics.22,23  We 
recognized that the 2-pyrone methyl coumalate (21), which can be obtained through the 
dimerization of malic acid, could be one such sustainable synthon as shown in Figure 1.  
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Figure 1.  Functionalized aromatics accessible via the methyl coumalate platform.  
 
Recently, Lee and Kraus reported an efficient biorenewable approach to commodity 
and specialty aromatic building blocks via a one-pot IEDDA/decarboxylation/elimination 
cascade.24  Through this methodology, methyl coumalate (21) was paired with readily 
accessible vinyl ethers, ketals, orthoesters and captodative dienophiles to produce green 
aromatics 23-29 in good to excellent yields with in exclusive regioselectivity.   
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In light of our laboratory’s successful prior work, extension of the coumalate 
platform to natural and synthetic carbazole alkaloids became our new challenging synthetic 
endeavor.  Carbazoles are a class of aromatic heterocycles that display a wide range of 
useful properties from therapeutic activities to applications in materials science as dyes, 
optoelectronics, and conducting polymers.  Consequently, synthetic developments in the 
area of carbazole alkaloids have intensified as seen by the comprehensive reviews and 
numerous research articles in recent years.25   
Carbazoles are mainly classified in two large groups based on their biogenesis.  The 
group of alkaloids isolated from plants contains a methyl unit or its oxygenated analogues 
at the 3-position of the carbazole skeleton.  On the other hand, the second group of 
carbazoles lacks the carbon substitution on the 3-position and are primarily isolated from 
microorganisms.  The vast majority of biologically active 3-methylcarbazole alkaloids are 
isolated from the Murraya, Clausena, and Glycomis species of the same plant from the 
family Rutaceae.26 These natural alkaloids exhibit antiviral, antimalarial, and antitumor 
activities as representative structures are shown in Figure 2.26,27,28   
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Figure 2. Representative structures of the 3-methylcarbazole family and its analogues. 
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Given the increasing importance of carbazole alkaloids, a broad array of synthetic 
strategies has been reported.  In recent years, the transition metal-catalyzed systems have 
been established as a general trend.  Some of the latest methods to construct the family of 
3-methylcarbazole or its higher oxidation state analogues 46 include Witulski’s [2+2+2] 
cycloaddition of diynes 47 and alkynes 48 in the presence of Wilkinson’s catalyst.29  
Subsequently, Back et al. described a Lewis acid-catalyzed Diels–Alder reaction between 
the vinylogous 2-(phenylthio)indole 49 and methyl propiolate (50) to form the desired 
carbazoles.30  In addition, Larock and co-workers designed an elegant pathway that 
featured in situ generation of an aryne intermediate from the silylaryl triflate 51 to first 
react with the 2-iodoanilines 52 to form the C–N bond, followed by palladium-catalyzed 
annulation to yield the aromatic heterocycles.31  In 2013, Itami and Lei reported a Pd-Cu-
Ag trimetallic protocol that coupled substituted indoles 53 and methyl acrylate (54) via a 
tandem C–H functionalization/Diels–Alder reaction as shown in Scheme 6.32  
Although these well-designed methods were able to generate targeted 3-
methylcarbazoles, they come with some practical challenges.  For example, the complete 
removal of transition-metal catalysts is important since the presence of metals could affect 
the bioactivity evaluation process. Particularly, the Itami and Lei protocol32 employs 
multiple metal catalysts, some of which are present in greater than stoichiometric amounts.  
In addition, highly substituted aromatic systems require multi-step preparations, which 
reduces the overall efficiency of the route.  Furthermore, the formation of regioisomeric 
mixtures is a potential risk if an unsymmetrical alkyne is chosen in Witulski’s method.29  
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Scheme 6. General approaches to carbazole alkaloids 46. 
   
 
 
52 
 
2.2. Results and Discussion  
 
We endeavored to design direct access to the family of naturally-occurring 
carbazole alkaloids 30-45 using the IEDDA methodology between indoles and methyl 
coumalate (21).  We recognized that two major potential challenges associated with 
electron-rich indole dienophiles needed to be addressed: (i) the nucleophilicity of the 3-
position of the indole and (ii) the ring-opening of the pyrrole component after the formation 
of the cycloadduct.   
First, the inherent reactivity pattern of indoles toward electrophilic nucleophilic 
substitutions has been one of the most well-characterized phenomena of indole chemistry.  
Significant delocalization of electron density from nitrogen to the C-3 postion of the indole 
was projected by molecular orbital calculations, and supported by experimental evidence.  
Halogenation, nitration, formylation, and sulfonation are just a few examples where the 3-
position of the indole was functionalized.33  More specifically, Snyder and co-workers 
reported that nucleophilic substitution reactions of indoles with methyl coumalate (21) 
occurred at the 3-position.21  
Secondly, the ring fragmentation of the pyrrole moiety of the Diels–Alder adduct 
via aromatization was first witnessed by Seitz (Scheme 1).7  Furthermore, Lee and Kraus 
exploited the one-pot Diels–Alder/decarboxylation/elimination pathway to obtain para-
substituted biphenyl alcohol 29 in 77% yield with benzofuran (55) and methyl coumalate 
(21) as shown in Scheme 7.24  Extrapolating the evidence to the targeted carbazoles, facile 
ring-opening was predicted to occur.   
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Scheme 7. Synthesis of biphenyl alcohol 29 by Lee and Kraus. 
  
After careful thinking we imagined functionalizing the 3-position of the indole with 
an activating group to depress its localized electron density and prevent detrimental 
nucleophilic additions.  Functionalization would also facilitate aromatization through 
elimination to efficiently construct the 3-methylcarbazole family without the need for 
transition metal-mediated oxidation.  Consequently, the activating group had to be mildly 
electron-withdrawing in nature to build a unidirectional dipole, which would ultimately 
assist in controlling the regioselectivity of the cycloaddition.  Selection of halides as 
activating groups was advantageous since the selective halogenation of the indole 3-
position was a well-established operation.  Additionally, their electronegativity would 
empower the regiospecificity of the intermolecular IEDDA reaction.  Overall, our proposed 
methodology hinged on the IEDDA-initiated cascade aromatization reaction between 
substituted 3-chloroindoles as dienophiles and methyl coumalate as the diene to reveal 
carbazole alkaloids, which was the first reaction of its kind.34   
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As shown in Scheme 8, we expected that 3-chloroindoles 57 would undergo an 
IEDDA reaction with methyl coumalate (21) to furnish the cycloadduct 58.  Afterwards, 
carbon dioxide extrusion from 58 was envisioned to occur, giving rise to the intermediate 
59, which would quickly aromatize by the elimination of hydrogen chloride to provide 
methyl carbazole-3-carboxylates 60. 
 
 
Scheme 8. Proposed mechanism to carbazoles by IEDDA/decarboxylation/aromatization. 
 
Our investigations began by subjecting methyl coumalate (21) and 3-chloroindole 
to 200 oC in toluene, which generated only a trace amount of methyl carbazole-3-
carboxylate (31) along with insoluble tars.  To avoid the tar formation, we screened other 
more polar solvents such as MeNO2, DMF, and MeCN, while keeping the other conditions 
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constant.  Unfortunately, changing the solvent did not decrease the tar accumulation during 
the reaction.  Thus, the complications led us to incorporate an alkyl unit or an electron-
donating protecting group on the 1-positions of the indole dienophile. 
 
Table 1. Reaction optimization with 1-methyl-3-chloroindole (57a)[a] 
 
entry solvent concn (M) temp (oC)  60a:57a ratio[b] 
1 toluene 0.10 200 1:0 
2 MeCN 0.05 200 1:1.3 
3 MeCN 0.10 165 1:2.9 
4 MeCN 0.15 200 1:0.6 
5 — neat 200 complex 
[a] All reactions were run for 16 h with 3.0 equivalents of methyl coumalate (21).  
[b] Ratios were determined by integration of crude 1H NMR. 
 
We then turned our attention to exploring the conditions with the 1-methyl-3-
chloroindole (57a) dienophile.  Pleasingly, the IEDDA reaction proceeded smoothly in 
toluene at 200 oC to give the corresponding carbazole 60a, observed by the crude 1H NMR 
(Table 1, entry 1).  Although other trials in MeCN at both 200 oC and 165 oC produced 
some carbazole 60a, the conversion of the indole starting material was not complete in 16 
hours with altered molar concentrations (Table 1, entries 2-4).  Additionally, the reaction 
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at 200 oC under neat conditions gave a complex mixure (Table 1, entry 5) as seen by the 
1H NMR.   
 
Table 2. Lewis acid-mediated IEDDA reaction of 57a and 21[a] 
 
entry Lewis acid Lewis acid equiv  60a:57a ratio[b] 
1 ZnCl2 0.1 1:3.4 
2 ZnCl2 1.0 1:1.5
[c] 
3 ZnCl2 2.0 1:0.2
[c] 
4 TiCl4 0.1 1:26 
5 SnCl4 0.1 1:20 
[a] All reactions were run at 150 oC for 16 h in toluene with 3.0 equivalents of methyl coumalate (21).  The 
concentration for all reactions was 0.1 M relative to 57a. Temperatures below 150 oC did not show product 
formation. 
[b] Ratios were determined by integration of crude 1H NMR. 
[c] Regioisomers (~ 1:1 ratio) were observed.  
  
 Once the heat-mediated IEDDA conditions were set for 1-methyl-3-chloroindole 
(57a), we also wanted to conduct a preliminary study with Lewis acids to lower the reaction 
temperature.  Mild Lewis acids such as ZnCl2 (0.1 equivalent) at 150 
oC displayed poor 
conversion giving a 1:3.4 (carbazole 60a : indole 57a) ratio (Table 2, entry 1).  Although 
increasing the Lewis acid amount to one and two equivalents with respect to the indole 
starting materials improved the conversion, the outcome of the reaction showed poor 
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regioselectivity.  In addition, intractable tar formation was observed, which would possibly 
be linked to indole oligomerization (Table 2, entries 2 and 3).  Switching to TiCl4 and SnCl4 
Lewis acids proved ineffective as they presented very low conversions (Table 2, entries 4 
and 5). Overall, the Lewis acid conditions were abandoned since no noticeable 
enhancements towards carbazoles was achieved.  
 Subsequently, in order to gain access to N-H functionalized carbazoles, we sought 
an electron-donating protecting group.  Our quest for a suitable candidate started with silyl 
groups.  Upon formation, the TMS, TBS, and TIPS-protected 3-chloroindoles were 
subjected to the IEDDA reaction with methyl coumalate (21) in toluene at 200 oC.  After a 
16 h time period, crude 1H NMR results showed only trace amounts of desired carbazole 
products along with significant quantities of starting materials and decomposition 
byproducts.  We then employed the acid-labile and electron-rich methoxymethyl ether 
protecting group, envisioning a strategy to promote the IEDDA-initiated cascade reaction 
followed by an in situ deprotection of the MOM group through the action of the HCl 
byproduct to deliver methyl carbazole-3-carboxylate (31). Unfortunately, only 
decomposition products were obtained as a result of the domino process.  We were 
rewarded in protecting group search when 1-benzyl-3-chloroindole (57b) proved to be 
stable at elevated temperatures.  
  Upon arriving at a good protecting group, we set out to systematically optimize the 
reaction conditions.  We selected 1-benzyl-3-chloroindole (57b) as the model system to 
investigate the parameters of time, equivalence of methyl coumalate (21), and 
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concentration. We settled on 200 oC as the reaction temperature since the lower 
temperatures did not provide enough activation energy for the system.  
As presented in Table 3, generally 16 h was necessary to generate carbazole 60b, 
as prolonging the reaction time did not make a significant impact in the product ratio.  In 
fact, undesirable tar formation was observed in entry 11 when the reaction was heated for 
48 hours, which accounted for the product loss. 
  
Table 3. Lewis acid-mediated IEDDA reaction of 57b and 21[a] 
 
entry time (h) equiv 21   concn (M) 60b:57b ratio[b] 
1 6 10 0.5 1:5.5 
2 16 10 0.2 1:0 
3 16 6 0.1 1:0.8 
4 16 6 0.2 1:0 
5 16 5 0.2 1:0.1 
6 16 5 0.2 1:0.1 
7 16 3 neat 1:2.4 
8 16 3 0.2 1:4.0 
9 16 3 0.05 1:6.7 
10 24 3 0.2 1:0.5 
11 48 3 0.2 1:0.4 
[a] All reactions were run at 200 oC in toluene. 
[b] Ratios were determined by integration of crude 1H NMR.  
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Furthermore, the relative equivalents of methyl coumalate (21) to indole 57b was 
investigated. A number of trials showed that excess equivalents of 21 promotes full 
conversion within 16 h.  Overall, the best conditions were achieved when 6 equivalents of 
21 reacted with 57b for in 0.2 M concentration for 16 hours as highlighted in Table 3, entry 
4.  
After optimizing the reaction conditions according to the model system, the stage 
was set for exploring the scope and limitations of our methodology.  We started with 57a 
which cleanly generated 60a in 90% yield.  This was very promising since similar 9-
alkylcarbazole-3-carboxylates show antiviral activity.  Moreover, 9-benzyl carbazole 60b 
was afforded in 65% yield.  Incorporation of electron-donating groups on the 5- and 7-
position of the indole was effective to improve the efficiency of the IEDDA cascade 
reaction, as was the case for 60c, which was isolated in 71% yield.  Indoles 57d and 57e, 
empowered by electron-rich methoxy substitutions, gave access to 60d and 60e in 80% and 
77% yields, respectively.  In addition, the methodology successfully produced 3-
carbomethoxy-11H-benzo[a]carbazole 60f in 67% yield as a single regioisomer.   
Our initial success with the electron-donating groups motivated us to investigate 
the influence of electron-withdrawing groups on the starting indole.  We envisioned that 
the construction of a halogen-substituted carbazole derivative would be a valuable synthon 
for further functionalization through the transition metal cross-coupling technologies. With 
that in mind, bromo-substituted carbazoles 60g and 60h were produced in 42% and 56% 
yields, respectively.  The lower yields were presumably due to the slower rate of the 
reaction caused by the inductively electron-withdrawing bromide moiety (Scheme 9).   
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Scheme 9. Scope and limitations of the methodology[a,b].  
[a] Reagents and conditions: 57a–k (1.0 equiv), 21 (6.0 equiv), toluene (0.2 M). All yields are isolated.  
Reaction time was 24 h for 60f–i. [b] Acetonitrile was used as the solvent for 60a. 
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Integration of the ester functionality on the indole was conveniently tolerated by 
the overall electronics of the system, giving rise to the symmetrical carbazole 60i in 49% 
yield.  Generally, the electron-deficient indoles 57f-i required longer reaction time frames 
compared to the parent indoles 57a-b. However, we did not prolong the reaction times 
more for than 24 hours from an efficiency standpoint. 
Lastly, the cyano- and nitro- substituents were too highly deactivating; thus, the 
formation of carbazoles 60j and 60k were not observed.  Nevertheless, these results 
verified the vital importance of effectively matching the electronics of the diene and the 
dienophile in IEDDA reactions.  
After demonstrating the scope and limitations of our methodology, we attempted 
to access the naturally occurring carbazoles via a trivial deprotection of the benzyl 
protecting group.  As shown in Scheme 10, AlCl3-mediated deprotection of 60b and 60d 
were accomplished in toluene at ambient temperature by altering the literature procedure35, 
affording the natural carbazole alkaloids 31 and 38 in 82% and 97% yields, respectively.   
The characterization data of 31 and 38 matched the previously reported literature 
values.28,36,37  
Overall, the successful debenzylation of the representative carbazoles paved the 
way for our method to potentially allow access to all the other natural carbazoles presented 
in Figure 2 by straightforward manipulation38 of the oxidation states.   
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Scheme 10. Synthesis of naturally occurring carbazoles 31 and 38 through deprotection[a]. 
[a] Reagents and conditions: 60b and 60d (1.0 equiv), AlCl3 (6.0 equiv), toluene (0.1 M), 23 oC, 6-24 h. 
 
2.3. Conclusions 
 
The Indole 2,3-carbon–carbon double bond moiety has been successfully exploited 
in IEDDA reactions to construct biologically active natural products ever since being 
uncovered by both Seitz and Takahashi.  The utility of the indole dienophiles were mostly 
restricted to electron-poor azadienes, o-azaquinones, and o-azaxylylenes in IEDDA 
reactions.  Inspired by our group’s prior achievements, we expanded the scope of the 
IEDDA reaction through demonstration of the first successful example of the IEDDA 
reaction between substituted indoles and a 2-pyrone methyl coumalate to efficiently 
synthesize carbazole alkaloids.  Our new methodology hinged on a thermally-induced, 
metal-free, single-pot IEDDA/decarboxylation/aromatization cascade sequence to produce 
carbazoles with exclusive regiospecificity.  The key to our success was the use of 1-alkyl-
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3-chloroindoles as the electron-rich dienophiles, since the presence of the chloride group 
was advantageous not only because of its easy introduction to the indole scaffold, but also 
to prevent ring-opening of the pyrrole component while promoting the aromatization.  In 
summary, this methodology provides a rapid route to natural and synthetic carbazoles in 
up to 90% yield, and holds potential applicability to complex alkaloids.   
 
2.4. Experimental 
 
General Procedures 
All starting materials were purchased from Sigma-Aldrich; solvents were 
purchased from Fisher Scientific and used without further purification.  Sodium hydride 
(60% in mineral oil) was purchased from TCI America.  All reactions were carried out in 
flame-dried glassware under argon with dry solvents under anhydrous conditions.  All 
yields refer to chromatographically isolated products.  Reactions were monitored by thin-
layer chromatography (TLC) carried out on 0.20 mm silica gel plates using UV light as a 
visualizing agent and either potassium permanganate or 5% sulfuric acid in methanol with 
heat as developing agents.  Silica gel 60Å, particle size 0.032 – 0.063 mm, was used for 
flash column chromatography.  1H and 13C NMR spectra were acquired in CDCl3 on a 
Varian MR-400 or Bruker Avance III 600 MHz spectrometer.  1H and 13C chemical shifts 
(δ) are given in ppm relative to the residual protonated solvent peak (CDCl3: δH = 7.26 
ppm, δC = 77.0 ppm; CD3OD: δH = 3.31 ppm, δC =49.0 ppm; (CD3)2SO: δH = 2.50 ppm, δC 
= 39.52 ppm; (CD3)2CO: δH = 2.05 ppm, δC = 29.84 ppm) as an internal reference.  High-
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resolution mass spectra (HRMS) were recorded on an Agilent 6540 QTOF (quadrupole 
time of flight) mass spectrometer using ESI (electrospray ionization) or APCI 
(atmospheric-pressure chemical ionization), or EI (electron ionization) on an Agilent 6890 
GC/MS. 
 
Selected Experimental, Physical, and Spectral Data 
Chlorination of indoles: 
 
 
 
3-Chloro-5-methoxy-1H-indole (62d).  The preparation of 62d is representative.  Over 
the course of the reaction, the flask was protected from light.  To a solution of 5-
methoxyindole 61d (2.0 g, 13.59 mmol) in DMF (56 mL) at room temperature was added 
NCS (1.91 g, 14.27 mmol).  The reaction was monitored by TLC to determine complete 
consumption of starting material.  (In most cases, the Rf of the starting material and product 
were very similar but differed when stained with 5% H2SO4/MeOH).  Afterwards, brine 
(30 mL) was added to the reaction mixture and the aqueous layer was extracted with ethyl 
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acetate (3 x 30 mL).  The organic layer was washed with water (3 x 30 mL) and brine (30 
mL), dried over sodium sulfate, and concentrated in vacuo.  The crude product was purified 
by flash column chromatography (silica gel, EtOAc:hexanes 1:9 to 2:8) to afford 62d (2.08 
g, 84% yield) as a white solid.  62d: Rf = 0.54 (silica gel, EtOAc:hexanes 1:2); 
1H NMR 
(CDCl3, 400 MHz) δ = 7.96 (brs, 1H), 7.25 (d, J = 8.0 Hz, 1H), 7.15 (d, J = 2.6 Hz, 1H), 
7.05 (d, J = 2.3 Hz, 1H), 6.90 (dd, J = 8.8, 2.3 Hz, 1H), 3.89 (s, 3H) ppm; 13C NMR (CDCl3, 
100 MHz) δ = 154.8, 129.9, 125.7, 121.4, 114.0, 112.4, 106.1, 99.2, 55.8 ppm; HRMS 
(APCI-TOF) calcd for C9H9ClNO [M + H]
+ 182.0367, found 182.0365. 
 
 
3-Chloroindole (62a = 62b).  Both 62a and 62b describe the same intermediate, which 
was prepared according to the literature procedure39 and all characterization data (1H NMR, 
13C NMR, and mass spectrometry) matched those previously reported. 
 
 
3-Chloro-5-methyl-1H-indole (62c):  White solid (0.27 g, 86% yield); Rf = 0.76 (silica 
gel, EtOAc:hexanes 1:1); 1H NMR (CDCl3, 400 MHz) δ = 7.95 (brs, 1H), 7.43 (s, 1H), 7.25 
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(d, J = 8.3 Hz, 1H), 7.14 (d, J = 2.6 Hz, 1H), 7.08 (dd, J = 8.4, 1.5 Hz, 1H), 2.48 (s, 3H) 
ppm; 13C NMR (CDCl3, 100 MHz) δ = 133.2, 129.9, 125.5, 124.8, 120.8, 117.7, 111.1, 
105.9, 21.4 ppm; HRMS (EI-TOF) calcd for C9H9ClN [M + H]
+ 166.0423, found 166.0427.  
 
 
3-Chloro-7-methoxy-1H-indole (62e):  Brown oil (0.26 g, 70% yield); Rf = 0.38 (silica 
gel, EtOAc:hexanes 1:3); 1H NMR (CDCl3, 600 MHz) δ = 8.28 (brs, 1H), 7.29 (dt, J = 8.1, 
0.8 Hz, 1H), 7.16 – 7.13 (m, 2H), 6.71 (dd, J = 7.7, 0.8 Hz, 1H), 3.98 (s, 3H) ppm; 13C 
NMR (CDCl3, 150 MHz) δ = 146.0, 126.6, 125.6, 120.8, 120.4, 110.7, 106.7, 102.6, 55.3 
ppm; HRMS (APCI-TOF) calcd for C9H9ClNO [M + H]
+ 182.0367, found 182.0362.  
 
 
3-Chloro-1H-benzo[g]indole (62f):  White-green solid (0.26 g, 73% yield); Rf = 0.36 
(silica gel, EtOAc:hexanes 1:3); 1H NMR (CDCl3, 600 MHz) δ = 8.74 (s, 1H), 7.96 (dd, J 
= 10.9, 8.2 Hz, 2H), 7.72 (d, J = 8.7 Hz, 1H), 7.59 (d, J = 8.6 Hz, 1H), 7.56 (ddd, J = 8.2, 
7.0, 1.2 Hz, 1H), 7.48 (ddd, J = 8.1, 7.0, 1.2 Hz, 1H), 7.24 (d, J = 2.6 Hz, 1H) ppm; 13C 
NMR (CDCl3, 150 MHz) δ = 130.8, 129.8, 129.1, 125.9, 124.6, 121.5 (2C), 121.4, 119.0, 
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118.9, 117.7, 108.2 ppm; HRMS (APCI-TOF) calcd for C12H8ClN [M + H]
+ 202.0418, 
found 202.0416. 
 
 
5-Bromo-3-chloro-1H-indole (62g = 62h):  (Both 62g and 62h describe the same 
intermediate).  White-purple solid (2.05 g, 87% yield); Rf = 0.79 (silica gel, EtOAc:hexanes 
1:1); 1H NMR (CDCl3, 400 MHz) δ = 8.13 (brs, 1H), 7.78 (d, J = 1.8 Hz, 1H), 7.33 (dd, J 
= 8.7, 1.8 Hz, 1H), 7.24 (d, J = 8.7 Hz, 1H), 7.19 (d, J = 2.6 Hz, 1H) ppm; 13C NMR 
(CDCl3, 100 MHz) δ = 133.5, 127.0, 126.1, 122.0, 120.9, 113.8, 112.9, 106.0 ppm; HRMS 
(EI-TOF) calcd for C8H6BrClN [M + H]
+ 229.9372, found 229.9368. 
 
 
Methyl 3-chloro-1-methylindole-5-carboxylate (57i):  White solid (0.44 g, 84% yield); 
Rf = 0.29 (silica gel, EtOAc:hexanes 1:3); 
1H NMR (CDCl3, 400 MHz) δ = 8.38 (d, J = 1.4 
Hz, 1H), 7.96 (dd, J = 8.7, 1.4 Hz, 1H), 7.30 (d, J = 8.7 Hz, 1H), 7.07 (s, 1H), 3.95 (s, 3H), 
3.78 (s, 3H) ppm; 13C NMR (CDCl3, 100 MHz) δ = 167.8, 138.1, 126.6, 125.3, 123.9, 122.0, 
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121.4, 109.3, 106.2, 51.9, 33.2 ppm; HRMS (APCI-TOF) calcd for C11H11ClNO2 [M + H]
+ 
224.0473, found 224.0469.  
  
 
3-Chloro-4-cyano-1H-indole (62j):  White solid (0.12 g, 97% yield); Rf = 0.07 (silica gel, 
EtOAc:hexanes 1:3); 1H NMR (CD3OD, 600 MHz) δ = 7.70 (d, J = 8.3 Hz, 1H), 7.52 – 
7.51 (m, 2H), 7.28 (t, J = 7.8 Hz, 1H) ppm; 13C NMR (CD3OD, 150 MHz) δ = 137.1, 128.3, 
126.7, 125.0, 123.2, 119.0, 118.5, 105.3, 101.9 ppm; HRMS (ESI-TOF) calcd for 
C9H6ClN2 [M + H]
+ 177.0214, found 177.0211.  
 
 
3-Chloro-5-nitro-1H-indole (62k).  Over the course of the reaction, the flask was 
protected from light.  To a solution of 5-nitroindole (61k) (1.00 g, 6.17 mmol) in DMF (10 
mL) at room temperature was added NCS (0.82 g, 6.18 mmol) and stirred for 20 hours.  
The reaction mixture was poured into water (100 mL) to generate a precipitate which was 
vacuum filtered and rinsed with water, then dried under vacuum to afford 62k (1.11 g, 91% 
yield) as a pure yellow solid. 62k: Rf = 0.53 (silica gel, EtOAc:hexanes 1:1); 
1H NMR 
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((CD3)2CO, 400 MHz) δ = 11.14 (brs, 1H), 8.47 (d, J = 2.2 Hz, 1H), 8.10 (dd, J = 9.0, 2.3 
Hz, 1H), 7.71 (s, 1H), 7.66 (d, J = 9.1 Hz, 1H) ppm; 13C NMR ((CD3)2CO, 100 MHz) δ = 
142.9, 139.1, 126.8, 125.4, 118.6, 115.2, 113.6, 107.7 ppm; HRMS (EI-TOF) calcd for 
C8H6ClN2O2 [M + H]
+ 197.0117, found 197.0120. 
 
Methylation of indoles: 
 
 
 
3-Chloro-7-methoxy-1-methylindole (57e).  The preparation of 57e is representative. To 
a suspension of sodium hydride (62 mg, 60% suspension in mineral oil, 1.55 mmol) in 
DMF (5 mL) at 0 oC was added a solution of 3-chloro-7-methoxy-1H-indole (62e) (235 
mg, 1.29 mmol) in DMF (3 mL), dropwise.  The reaction mixture was warmed to room 
temperature and stirred for 30 minutes then cooled to 0 oC.   Methyl iodide (0.10 mL, 1.68 
mmol) was added dropwise at 0 oC, after which the reaction was warmed to room 
temperature and monitored by TLC.  After approximately 1 hour, a saturated ammonium 
chloride solution (30 mL) was carefully added, and the aqueous layer was extracted with 
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diethyl ether (3 x 30 mL).  The combined organic phases were washed with brine (30 mL), 
dried over sodium sulfate, and concentrated in vacuo.  The crude product was purified by 
flash column chromatography (silica gel, EtOAc:hexanes 1:9 to 2:8) to afford 57e (226 
mg, 89% yield) as a pale tan solid.  57e: Rf = 0.54 (silica gel, EtOAc:hexanes 1:3);
 1H NMR 
(CDCl3, 400 MHz) δ = 7.21 (d, J = 8.0 Hz, 1H), 7.06 (t, J = 7.9 Hz, 1H), 6.90 (s, 1H), 6.65 
(d, J = 7.7 Hz, 1H), 4.02 (s, 3H), 3.93 (s, 3H) ppm; 13C NMR (CDCl3, 100 MHz) δ = 147.8, 
127.9, 126.2, 125.6, 120.4, 111.0, 104.1, 103.0, 55.4, 36.6 ppm; HRMS (APCI-TOF) calcd 
for C10H11ClNO [M + H]
+ 196.0524, found 163.0520. 
 
 
3-Chloro-1-methylindole (57a):  57a was prepared according to the literature procedure40 
and all characterization data (1H NMR, 13C NMR, and mass spectrometry) matched those 
previously reported. 
 
 
3-Chloro-1-methylbenzo[g]indole (57f):  Pale yellow solid (0.30 g, 97% yield); Rf = 0.57 
(silica gel, EtOAc:hexanes 1:3); 1H NMR (CDCl3, 400 MHz) δ = 8.44 (d, J = 8.4 Hz, 1H), 
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7.97 (d, J = 8.0 Hz, 1H), 7.70 (d, J = 8.6 Hz, 1H), 7.58 – 7.54 (m, 2H), 7.47 (t, J = 8.3, 
1H), 7.05 (s, 1H), 4.26 (s, 3H) ppm; 13C NMR (CDCl3, 100 MHz) δ = 131.6, 129.4, 129.3, 
125.6, 125.3, 123.9, 123.1, 123.0, 121.6, 120.7, 117.8, 105.3, 38.6 ppm; HRMS (APCI-
TOF) calcd for C13H10ClN [M + H]
+ 216.0575, found 216.0573.   
 
 
5-Bromo-3-chloro-1-methylindole (57h):  Pale yellow solid (0.49 g, 92% yield); Rf = 
0.54 (silica gel, EtOAc:hexanes 1:3); 1H NMR (CDCl3, 400 MHz) δ = 7.74 (dd, J = 1.8, 0.6 
Hz, 1H), 7.33 (dd, J = 8.7, 1.9 Hz, 1H), 7.16 (dd, J = 8.7, 0.6 Hz, 1H), 7.01 (s, 1H), 3.73 
(s, 3H) ppm; 13C NMR (CDCl3, 100 MHz) δ = 134.4, 127.2, 126.3, 125.5, 120.9, 113.3, 
111.0, 103.8, 33.1 ppm; HRMS (EI-TOF) calcd for C9H8BrClN [M + H]
+ 243.9528, found 
243.9524.   
 
 
3-Chloro-4-cyano-1-methylindole (57j):  Yellow solid (0.10 g, 83% yield); Rf = 0.42 
(silica gel, EtOAc:hexanes 1:1); 1H NMR (CDCl3, 600 MHz) δ = 7.52 (d, J = 8.4 Hz, 1H), 
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7.48 (d, J = 7.3 Hz, 1H), 7.26 (t, J = 7.9 Hz, 1H), 7.16 (s, 1H), 3.81 (s, 3H) ppm; 13C NMR 
(CDCl3, 150 MHz) δ = 135.8, 128.4, 127.0, 124.3, 122.0, 117.7, 114.4, 104.0, 101.9, 33.2 
ppm; HRMS (ESI-TOF) calcd for C10H8ClN2 [M + H]
+ 191.0371, found 191.0370.   
 
 
Methyl 1-methylindole-5-carboxylate (61i):  To a suspension of sodium hydride (273 
mg, 60% suspension in mineral oil, 6.82 mmol) in DMF (9 mL) at 0 oC was added a 
solution of 1H-indole-5-carboxylic acid (500 mg, 3.10 mmol) in DMF (9 mL), dropwise.  
The reaction mixture was warmed to room temperature and stirred for 30 minutes then 
cooled to 0 oC.   Methyl iodide (0.48 mL, 7.75 mmol) was added dropwise at 0 oC, after 
which the reaction was warmed to room temperature and monitored by TLC.  After 
approximately 1 hour, a saturated ammonium chloride solution (10 mL) was carefully 
added, and the aqueous layer was extracted with diethyl ether (3 x 10 mL).  The combined 
organic phases were washed with water (2 x 10 mL), brine (10 mL), dried over sodium 
sulfate, and concentrated in vacuo to afford pure 61i (0.52 g, 88% yield) as a yellow solid.  
61i: Rf = 0.44 (silica gel, EtOAc:hexanes 1:3);
 1H NMR (CDCl3, 400 MHz) δ = 8.40 (s, 
1H), 7.93 (d, J = 8.7 Hz, 1H), 7.33 (d, J = 8.7 Hz, 1H), 7.11 (d, J = 3.1 Hz, 1H), 6.59 (d, J 
= 3.4 Hz, 1H), 3.93 (s, 3H), 3.82 (s, 3H) ppm; 13C NMR (CDCl3, 100 MHz) δ = 168.2, 
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139.1, 130.2, 127.9, 123.9, 122.9, 121.3, 108.8, 102.6, 51.8, 33.0 ppm; HRMS (EI-TOF) 
calcd for C11H12NO2 [M + H]
+ 190.0868, found 190.0871.   
 
Benzylation of indoles: 
 
 
 
1-Benzyl-3-chloro-5-methoxyindole (57d):  The preparation of 57d is representative. To 
a solution of 3-chloro-5-methoxy-1H-indole (62d) (0.71 g, 3.89 mmol) in DMF (4 mL) 
was added NaH (19 mg, 60% suspension in mineral oil, 4.67 mmol) at 0 oC.  The reaction 
mixture was warmed to room temperature and stirred for 30 minutes then cooled to 0 oC.   
Benzyl bromide (0.51 mL, 4.28 mmol) was added dropwise at 0 oC, after which the reaction 
was warmed to room temperature and monitored by TLC.  After approximately 1 hour, the 
reaction was carefully quenched with a saturated ammonium chloride solution (30 mL) 
was added and the aqueous layer was extracted with diethyl ether (3 x 30 mL).  The 
combined organic layers were washed with brine (30 mL), dried over sodium sulfate, and 
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concentrated in vacuo.  The crude product was purified by flash column chromatography 
(silica gel, EtOAc:hexanes 1:9 to 2:8) to afford 57d (1.06 g, 94% yield) as a white solid. 
57d: Rf = 0.60 (silica gel, EtOAc:hexanes 1:3);
 1H NMR (CDCl3, 400 MHz) δ = 7.34 – 7.27 
(m, 3H), 7.16 (d, J = 8.9 Hz, 1H), 7.13 – 7.09 (m, 2H), 7.06 (s, 1H), 7.05 (d, J = 2.4 Hz, 
1H), 6.87 (dd, J = 8.9, 2.5 Hz, 1H), 5.24 (s, 2H), 3.88 (s, 3H) ppm; 13C NMR (CDCl3, 100 
MHz) δ = 154.6, 136.9, 130.6, 128.8, 127.8, 126.8, 126.3, 125.0, 113.6, 111.0, 104.5, 99.4, 
55.7, 50.4 ppm; HRMS (APCI-TOF) calcd for C16H15ClNO [M + H]
+ 272.0837, found 
272.0840. 
 
 
1-Benzyl-3-chloroindole (57b):  Yellow solid (1.59 g, 79% yield); Rf = 0.50 (silica gel, 
EtOAc:hexanes 1:9); 1H NMR (CDCl3, 600 MHz) δ = 7.64 (dd, J = 7.6, 1.2 Hz, 1H), 7.33 
– 7.28 (m, 4H), 7.23 (t, J = 7.2 Hz, 1H), 7.19 (t, J = 7.3 Hz, 1H), 7.13 (d, J = 7.1 Hz, 2H), 
7.09 (s, 1H), 5.28 (s, 2H) ppm; 13C NMR (CDCl3, 150 MHz) δ = 136.8, 135.5, 128.9, 127.9, 
126.9, 126.0, 124.6, 122.8, 120.2, 118.5, 109.9, 105.3, 50.2 ppm; HRMS (APCI-TOF) 
calcd for C15H13ClN [M + H]
+ 242.0731, found 242.0731. 
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1-Benzyl-3-chloro-5-methylindole (57c):  Yellow oil (0.37 g, 88% yield); Rf = 0.74 (silica 
gel, EtOAc:hexanes 1:3); 1H NMR (CDCl3, 400 MHz) δ = 7.46 (s, 1H), 7.33 – 7.29 (m, 
3H), 7.19 (d, J = 8.5 Hz, 1H), 7.15 – 7.11 (m, 2H), 7.09 – 7.06 (m, 2H), 5.24 (s, 2H), 2.50 
(s, 3H) ppm; 13C NMR (CDCl3, 100 MHz) δ = 136.9, 133.9, 129.6, 128.8, 127.8, 126.8, 
126.1, 124.6, 124.5, 118.0, 109.7, 104.6, 50.2, 21.4 ppm; HRMS (APCI-TOF) calcd for 
C16H15ClN [M + H]
+ 256.0893, found 256.0888. 
 
 
1-Benzyl-5-bromo-3-chloroindole (57g):  Yellow solid (1.43 g, 94% yield); Rf = 0.63 
(silica gel, EtOAc:hexanes 1:3); 1H NMR (CDCl3, 400 MHz) δ = 7.77 (d, J = 1.8 Hz, 1H), 
7.32 – 7.28 (m, 4H), 7.14 (d, J = 8.8 Hz, 1H), 7.11 – 7.09 (m, 3H), 5.25 (s, 2H) ppm; 13C 
NMR (CDCl3, 100 MHz) δ = 136.3, 134.1, 128.9, 128.1, 127.5, 126.8, 125.8 (2C), 121.1, 
113.6, 111.5, 104.6, 50.4 ppm; HRMS (APCI-TOF) calcd for C15H12BrClN [M + H]
+ 
319.9836, found 319.9835.   
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1-Benzyl-3-chloro-5-nitroindole (57k):  Yellow-orange solid (0.71 g, 98% yield); Rf = 
0.38 (silica gel, EtOAc:hexanes 1:3); 1H NMR (CDCl3, 600 MHz) δ = 8.62 (d, J = 2.2 Hz, 
1H), 8.13 (dd, J = 9.1, 2.3 Hz, 1H), 7.35 – 7.33 (m, 4H), 7.24 (s, 1H), 7.13 (dd, J = 7.9, 1.6 
Hz, 2H), 5.33 (s, 2H) ppm; 13C NMR (CDCl3, 150 MHz) δ = 142.2, 138.0, 135.4, 129.2, 
128.5, 127.7, 126.9, 125.5, 118.4, 116.1, 110.2, 108.1, 50.8 ppm; HRMS (ESI-TOF) calcd 
for C15H12ClN2O2 [M + H]
+ 287.0583, found 287.0584. 
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IEDDA/decarboxylation/aromatization reaction to carbazoles: 
 
 
 
Methyl 9-benzyl-6-methoxycarbazole 3-carboxylate (60d):  The preparation of 60d is 
representative, with the exception of 60f-60i which were run for 24 hours.  To a sealable 
65-mL pressure vessel was successively added 1-benzyl-3-chloro-5-methoxyindole 57d 
(100 mg, 0.37 mmol), methyl coumalate (21) (340 mg, 2.2 mmol), and toluene (1.8 mL) 
under argon.  The solution was heated to 200 oC and stirred for 16 h.  Upon completion of 
the reaction, the sealable pressure vessel was cooled to room temperature.  The solution 
was transferred to another flask, while rinsing with ethyl acetate, after which the solution 
was concentrated in vacuo.  The crude product was purified by flash column 
chromatography (silica gel, EtOAc:hexanes 1:9 to 2:8) to afford 60d (0.10 g, 80% yield) 
as a yellow solid.  60d: Rf = 0.46 (silica gel, EtOAc:hexanes 1:3);
 1H NMR (CDCl3, 400 
MHz) δ = 8.82 (d, J = 1.2 Hz, 1H), 8.12 (dd, J = 8.7, 1.7 Hz, 1H), 7.66 (d, J = 2.4 Hz, 1H), 
7.34 (d, J = 8.6 Hz, 1H), 7.29 – 7.23 (m, 4H), 7.13 – 7.07 (m, 3H), 5.50 (s, 2H), 3.97 (s, 
3H), 3.94 (s, 3H) ppm; 13C NMR (CDCl3, 100 MHz) δ = 167.8, 154.5, 143.7, 136.6, 136.0, 
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128.9, 127.6, 127.4, 126.3, 123.6, 122.9, 122.6, 120.6, 115.8, 110.2, 108.5, 103.4, 56.0, 
51.9, 46.8 ppm; HRMS (APCI-TOF) calcd for C22H20NO3 [M + H]
+ 346.1438, found 
346.1441. 
 
 
Methyl 9-methylcarbazole-3-carboxylate (60a):  White solid (65 mg, 90% yield); Rf = 
0.73 (silica gel, EtOAc:hexanes 1:1); 1H NMR (CDCl3, 400 MHz) δ = 8.82 (d, J = 1.6 Hz, 
1H), 8.18 (dd, J = 8.6, 1.7 Hz, 1H), 8.14 (dt, J = 7.9, 0.9 Hz, 1H), 7.52 (ddd, J = 8.3, 7.2, 
1.2 Hz, 1H), 7.42 (d, J = 8.2 Hz, 1H), 7.38 (d, J = 8.6 Hz, 1H), 7.30 (t, J = 7.4 Hz, 1H), 
3.98 (s, 3H), 3.85 (s, 3H) ppm; 13C NMR (CDCl3, 100 MHz) δ = 167.9, 143.5, 141.5, 127.3, 
126.4, 122.9, 122.8, 122.5, 120.7, 120.6, 119.9, 108.8, 107.9, 51.9, 29.2 ppm; HRMS (ESI-
TOF) calcd for C15H14NO2 [M + H]
+ 240.1019, found 240.1022.   
 
 
Methyl 9-benzylcarbazole-3-carboxylate (60b):  Yellow solid (42 mg, 65% yield); Rf = 
0.47 (silica gel, EtOAc:hexanes 1:3); 1H NMR (CDCl3, 400 MHz) δ = 8.87 (dd, J = 1.6, 
0.6 Hz, 1H), 8.18 (dt, J = 8.0, 1.0 Hz, 1H), 8.14 (dd, J = 8.6, 1.7 Hz, 1H), 7.47 (ddd, J = 
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8.3, 7.1, 1.2 Hz, 1H), 7.41 – 7.35 (m, 2H), 7.34 – 7.29 (m, 1H), 7.29 – 7.24 (m, 3H), 7.13 
(dd, J = 7.6, 1.8 Hz, 2H), 5.53 (s, 2H), 3.98 (s, 3H) ppm; 13C NMR (CDCl3, 100 MHz) δ = 
167.8, 143.3, 141.2, 136.4, 128.9, 127.7, 127.5, 126.6, 126.3, 123.1, 122.9, 122.8, 121.1, 
120.7, 120.2, 109.3, 108.4, 51.9, 46.7 ppm; HRMS (APCI-TOF) calcd for C21H18NO2 [M 
+ H]+ 316.1332, found 316.1336.  
 
 
Methyl 9-benzyl-6-methylcarbazole-3-carboxylate (60c):  Pale brown solid (45 mg, 
71% yield); Rf = 0.51 (silica gel, EtOAc:hexanes 1:3); 
1H NMR (CDCl3, 600 MHz) δ = 
8.80 (d, J = 2.0 Hz, 1H), 8.09 (d, J = 8.6 Hz, 1H), 7.95 (s, 1H), 7.29 (d, J = 8.6 Hz, 1H), 
7.25 – 7.19 (m, 5H), 7.08 (d, J = 7.0 Hz, 2H), 5.45 (s, 2H), 3.94 (s, 3H), 2.52 (s, 3H) ppm; 
13C NMR (CDCl3, 100 MHz) δ = 167.8, 143.5, 139.4, 136.6, 129.6, 128.8, 127.8, 127.6, 
127.3, 126.3, 123.2, 122.8, 122.6, 120.8, 120.6, 109.0, 108.3, 51.9, 46.7, 21.4 ppm; HRMS 
(APCI-TOF) calcd for C22H20NO2 [M + H]
+ 330.1489, found 330.1492. 
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Methyl 8-methoxy-9-methylcarbazole-3-carboxylate (60e): Pale yellow solid (53 mg, 
77% yield); Rf = 0.43 (silica gel, EtOAc:hexanes 1:3); 
1H NMR (CDCl3, 400 MHz) δ = 
8.78 (s, 1H), 8.16 (d, J = 8.6 Hz, 1H), 7.74 (d, J = 7.8 Hz, 1H), 7.36 (d, J = 8.7 Hz, 1H), 
7.18 (t, J = 7.8 Hz, 1H), 6.95 (d, J = 7.9 Hz, 1H), 4.17 (s, 3H), 3.99 (s, 3H), 3.98 (s, 3H) 
ppm; 13C NMR (CDCl3, 100 MHz) δ = 167.9, 147.1, 143.8, 130.7, 127.0, 124.7, 122.8, 
122.5, 120.5, 120.3, 113.0, 108.1, 107.7, 55.6, 51.8, 32.4 ppm; HRMS (APCI-TOF) calcd 
for C16H16NO3 [M + H]
+ 270.1125, found 270.1124.   
 
 
Methyl 11-methylbenzo[a]carbazole-8-carboxylate (60f):  Yellow solid (45 mg, 67% 
yield); Rf = 0.52 (silica gel, EtOAc:hexanes 1:3); 
1H NMR (CDCl3, 600 MHz,) δ = 8.89 (d, 
J = 1.6 Hz, 1H), 8.70 (d, J = 8.5 Hz, 1H), 8.22 – 8.19 (m, 2H), 8.06 (d, J = 8.0 Hz, 1H), 
7.72 (d, J = 8.5 Hz, 1H), 7.62 (t, J = 8.2 Hz, 1H), 7.57 (d, J = 7.9 Hz, 1H), 7.54 (d, J = 8.7 
Hz, 1H), 4.43 (s, 3H), 4.00 (s, 3H) ppm; 13C NMR (CDCl3, 150 MHz) δ = 167.9, 143.1, 
136.2, 133.8, 129.5, 126.1, 125.5, 125.0, 122.6 (2C), 122.4, 121.9, 121.5, 121.4, 119.3, 
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119.0, 108.6, 52.0, 34.3 ppm; HRMS (ESI-TOF) calcd for C19H16NO2 [M + H]
+ 290.1176, 
found 290.1179.    
 
 
Methyl 9-benzyl-6-bromocarbazole-3-carboxylate (60g):  White-orange solid (52 mg, 
42% yield); Rf = 0.50 (silica gel, EtOAc:hexanes 1:3); 
1H NMR (CDCl3, 400 MHz) δ = 
8.75 (d, J = 1.7 Hz, 1H), 8.23 (d, J = 1.9 Hz, 1H), 8.13 (dd, J = 8.6, 1.7 Hz, 1H), 7.50 (dd, 
J = 8.7, 1.8 Hz, 1H), 7.33 (d, J = 8.7 Hz, 1H), 7.29 – 7.23 (m, 3H), 7.20 (d, J = 8.7 Hz, 
1H), 7.09 – 7.05 (m, 2H), 5.44 (s, 2H), 3.96 (s, 3H) ppm; 13C NMR (CDCl3, 100 MHz) δ 
= 167.5, 143.4, 139.8, 135.9, 129.2, 128.9, 128.1, 127.8, 126.2, 124.8, 123.4, 123.0, 121.7, 
121.6, 113.1, 110.8, 108.6, 52.0, 46.8 ppm; HRMS (APCI-TOF) calcd for C21H17BrNO2 
[M + H]+ 394.0437, found 394.0438.   
 
 
Methyl 6-bromo-9-methylcarbazole-3-carboxylate (60h):  Pale tan solid (37 mg, 56% 
yield); Rf = 0.23 (silica gel, EtOAc:hexanes 1:3);
 1H NMR (CDCl3, 600 MHz) δ = 8.77 (d, 
J = 1.3 Hz, 1H), 8.25 (d, J = 1.9 Hz, 1H), 8.20 (dd, J = 8.6, 1.6 Hz, 1H), 7.60 (dd, J = 8.6, 
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1.9 Hz, 1H), 7.40 (d, J = 8.6 Hz, 1H), 7.30 (d, J = 8.6 Hz, 1H), 3.98 (s, 3H), 3.86 (s, 3H) 
ppm; 13C NMR (CDCl3, 150 MHz) δ = 167.6, 143.7, 140.2, 129.0, 127.9, 124.5, 123.3, 
123.0, 121.4, 121.2, 112.8, 110.3, 108.2, 52.0, 29.4 ppm; HRMS (APCI-TOF) calcd for 
C15H13BrNO2 [M + H]
+ 318.0124, found 318.0124.   
 
 
Dimethyl 9-methylcarbazole-3,6-dicarboxylate (60i):  Pale yellow solid (33 mg, 49% 
yield); Rf = 0.61 (silica gel, EtOAc:hexanes 1:1);
 1H NMR (CDCl3, 400 MHz) δ = 8.82 (s, 
2H), 8.20 (d, J = 8.5 Hz, 2H), 7.39 (d, J = 8.6 Hz, 2H), 3.98 (s, 6H), 3.86 (s, 3H) ppm; 13C 
NMR (CDCl3, 100 MHz) δ = 167.5, 144.1, 127.9, 122.9, 122.6, 121.8, 108.4, 52.0, 29.5 
ppm; HRMS (APCI-TOF) calcd for C17H16NO4 [M + H]
+ 298.1074, found 298.1072.   
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Deprotection of carbazoles: 
 
 
 
Methyl 9H-carbazole-3-carboxylate (31):  The preparation of 31 is representative, but 
methyl 9-benzyl-6-methoxycarbazole-3-carboxylate (60d) only required 6 hours.  To a 
suspension of AlCl3 (80 mg, 0.6 mmol) in toluene (1 mL) at room temperature was added 
a solution of methyl 9-benzylcarbazole-3-carboxylate (60b) (32 mg, 0.1 mmol) in toluene 
(1 mL), dropwise.  The mixture was stirred at room temperature and monitored by TLC for 
complete consumption of starting material.  After 24 hours, the reaction was quenched with 
saturated sodium bicarbonate (5 mL), diluted with dichloromethane (10 mL), and the 
organic layer washed with saturated sodium bicarbonate (2 x 5 mL) and brine (5 mL), dried 
over sodium sulfate, and concentrated in vacuo.  The crude product was purified by flash 
column chromatography (silica gel, EtOAc:hexanes 1:3) to afford 31 (19 mg, 82% yield) 
as pale yellow solid.  (The natural product NMR data was reported in both CDCl3 and 
(CD3)2SO to compare the spectra in the same originally reported solvent and to provide 
another experimentally convenient comparison).  31: Rf = 0.40 (silica gel, EtOAc:hexanes 
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1:3); 1H NMR (CDCl3, 400 MHz) δ = 8.83 – 8.82 (m, 1H), 8.36 (s, 1H), 8.13 (ddd, J = 7.9, 
4.5, 1.3 Hz, 2H), 7.47 – 7.46 (m, 2H), 7.43 (dd, J = 8.5, 0.7 Hz, 1H), 7.32 – 7.28 (m, 1H), 
3.98 (s, 3H) ppm; 13C NMR (CDCl3, 101 MHz) δ = 167.9, 142.2, 139.9, 127.4, 126.6, 
123.3, 123.1, 122.9, 121.4, 120.6, 120.3, 110.9, 110.1, 52.0 ppm; 1H NMR ((CD3)2SO, 600 
MHz) δ = 11.71 (s, 1H), 8.79 (s, 1H), 8.26 (d, J = 7.7 Hz, 1H), 8.02 (d, J = 8.9 Hz, 1H), 
7.55 (t, J = 9.4 Hz, 2H), 7.45 (t, J = 7.4 Hz, 1H), 7.23 (t, J = 7.4 Hz, 1H), 3.89 (s, 3H) ppm; 
13C NMR ((CD3)2SO, 150 MHz) δ = 166.9, 142.6, 140.3, 126.7, 126.4, 122.4, 122.3, 122.2, 
120.7, 119.8, 119.5, 111.4, 110.8, 51.7 ppm; HRMS (APCI-TOF) calcd for C14H12NO2 [M 
+ H]+ 224.0863, found 226.0860. 
 
 
Methyl 6-methoxy-9H-carbazole-3-carboxylate (38):  (The natural product NMR data 
was reported in both CDCl3 and (CD3)2CO to compare the spectra in the same originally 
reported solvent and to provide another experimentally convenient comparison).  Yellow 
solid (21 mg, 97% yield); Rf = 0.55 (silica gel, EtOAc:hexanes 1:1);
 1H NMR (CDCl3, 600 
MHz) δ = 8.78 – 8.77 (m, 1H), 8.21 (s, 1H), 8.11 (dd, J = 8.5, 1.7 Hz, 1H), 7.60 (d, J = 2.4 
Hz, 1H), 7.38 (dd, J = 26.8, 8.6 Hz, 2H), 7.10 (dd, J = 8.7, 2.5 Hz, 1H), 3.98 (s, 3H), 3.94 
(s, 3H) ppm; 13C NMR (CDCl3, 150 MHz) δ = 167.9, 154.5, 142.9, 134.6, 127.3, 123.8, 
123.1, 122.9, 121.0, 115.9, 111.6, 110.2, 103.2, 56.0, 51.9 ppm; 1H NMR ((CD3)2CO, 600 
MHz) δ = 10.55 (s, 1H), 8.80 (s, 1H), 8.04 (d, J = 8.5 Hz, 1H), 7.84 (s, 1H), 7.54 (d, J = 
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8.5 Hz, 1H), 7.47 (d, J = 8.7 Hz, 1H), 7.09 (d, J = 8.7 Hz, 1H), 3.93 (s, 3H), 3.91 (s, 3H) 
ppm; 13C NMR ((CD3)2CO, 150 MHz) δ = 168.0, 155.4, 144.3, 136.2, 127.6, 124.5, 123.8, 
123.4, 121.3, 116.8, 112.9, 111.4, 103.8, 56.1, 51.9 ppm; HRMS (ESI-TOF) calcd for 
C15H14NO3 [M + H]
+ 256.0968, found 256.0965. 
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CHAPTER 3. 
CONCISE SYNTHESIS OF FLUORESCENT ROSAMINE PROBES FOR 
CELLULAR IMAGING† 
 
3.1. Introduction 
 
Live-cell imaging has become one of the most indispensable tools in biochemistry 
and biology to visualize a broad spectrum of phenomena from the way proteins in cells 
translate signals in their intracellular networks to the dynamics of cell-cell interactions that 
are responsible for life.1  Live-cell imaging technologies have been synergistically 
supported by continued advancements in fluorescent microscopy, identification of natural 
and synthetic fluorescent probes, and the development of biomolecule labelling methods.2,3  
 In particular, driven by the growing interest in cellular imaging applications, 
designing diverse fluorophores has been an active research area to facilitate the labelling 
of a broader range of intracellular biomolecules including RNA.  These probes are 
generally categorized into two main groups.  The first group is defined as the labelling 
agent, which can be florescent dyes or radionuclides.  They are employed to show the 
localization and/or concentration of their covalently-attached specific biomolecules.  The 
second group of imaging probes contains sensors that generate a luminescence signal only 
after their recognition of specific target biomolecules.4  
                                                 
† Adapted with permission from Kraus, G. A.; Guney, T.; Kempema, A.; Hyman, J. M.; Parvin, B., 
Tetrahedron Lett. 2014, 55, 1549-1551.  Copyright © 2014 Elsevier. 
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 Organic synthesis has been instrumental in providing the flexibility to tailor the 
desired imaging probes with diverse properties necessary to address various biological 
questions through live-cell imaging.5  Some of the desired properties of these probes 
involve being bright and photostable, nontoxic, permeable across membranes, and 
accommodating for adequate contrast between the biomolecule of interest and the 
background noise.3   
Two major complementary synthetic technologies have been used in the probe 
development process.  The target-oriented synthetic approach has been selected when a 
particular biological system, which was either in vitro or in vivo, was sufficiently defined 
or a previous library screening method identified imaging probe candidates.  Therefore, the 
necessary fluorophores can be synthesized based upon a rational design procedure.  
However, in most cases, the lack of understanding of biological actions at the molecular 
level has hindered the strategy of creating probes in a rational manner.    
An alternative, diversity-oriented synthetic approach, has recently emerged, which 
is built on a rapid and systematic diversification of the chemical space through organic 
synthesis.  The high throughput screening of the combinatorial imaging probe libraries that 
was made accessible by the diversity-oriented synthesis has led to the discovery of 
numerous new probes for particular biomolecular targets.6    
Through the use of recently advanced novel synthetic routes as well as the further 
optimization of known syntheses, small-molecule florescent probe libraries have 
significantly been expanded as representative structures are shown in Figure 1.  These 
fluorescent molecules 1-9 display emission spectra from the blue to near-infrared region.7  
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Figure 1. Representative common structures of small-molecule fluorescent probes.  
 
 An important class of fluorescent probes are embodied by the tricyclic xanthene 
scaffold 10, such as fluorescein (5), rhodamine 7, and rosamine 8.  Because of their 
exceptional photophysical properties coupled with their high photostability and high 
quantum yield, xanthylium-based fluorophores are widely employed in imaging 
applications.8  For instance, as one of the few fluorescent molecules that is approved by 
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the U.S. Food and Drug Administration, fluorescein (5) has been used in clinical 
angiographic applications for over 50 years to diagnose and treat retinal disorders.9  In 
addition, rhodamine B (11) has been utilized as a fluorescence quantum yield standard, a 
histology stain, a chemosensor for metal ions, as well as a pH indicator.10  Similarly, 
rosamines can be used as photosensitizers and stains in biological applications.11  For 
example, rosamine CDy1 (12) has been described as the first selective biomarker for both 
embryonic and induced pluripotent stem cells as the structures shown in Figure 2.12  
In terms of the structural features, both fluorescein (5) and rhodamine B (11) are 
substituted with a carboxylic acid functionality on the 2’-position, which regulates the 
fluorescence level by restraining the free rotation of the 9-phenyl ring.  In contrast, 
rosamine 12 lacks the 2’-carboxylic acid moiety.  Moreover, rhodamines and rosamines 
are distinguished from fluorescein (5) by the alkylamino substututions on the 3- and 6- 
positions of the xanthylium core.  
 
Figure 2. Structures of xanthene (10), rhodamine B (11) and rosamine CDy1 (12). 
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 In particular, rosamines have gained considerable interest in the areas of cancer13, 
stem-cell14, and most recently, neurodegenerative disorder research including the 
investigations of therapeutic strategies for Alzheimer’s disease.15  Preparation of the first 
combinatorial rosamine library by Chang and co-workers made a notable impact to unlock 
the undervalued potential of rosamines in biomedical research.16 
 Historically, rosamine dyes were first discovered by Heumann and Rey in 1889.17  
The synthesis of tetramethylrosamine chloride (13) was achieved when 3-
(dimethylamino)phenol (14) was condensed with benzotrichloride (15) in benzene as 
shown in Scheme 1.  They also reported that rosamine 13 was very soluble in both water 
and alcohols, possessed a purplish color in visible light, as well as produced an intense 
orange fluorescence.  Numerous rosamines have since been prepared through the 
manipulation of not only the functional groups substituted on the 3-, 6-, and 9-positions of 
the  xanthylium scaffold but also the counterions to explore the fluorescence characteristics 
to be able to exploit various applications. 
 
 
Scheme 1. First synthesis of rosamines by Heumann and Rey.17 
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 To date, three distinct synthetic strategies have been effective for the formation of 
rosamines coupled with either a solution or a solid-phase approach.  The condensation 
route, which was the first reported protocol, has been further extended to incorporate a 
number of aromatic aldehydes 16 and 3-aminophenols 17 in the presence of an acid catalyst 
or an oxidant to efficiently access various rosamine dyes 18 as shown in Scheme 2.  
Although the solution-based condensation methodology is one of the well-established 
paths to rosamines, it often requires high temperatures that results in complex mixtures.  
Recently, Burgess and co-workers introduced a microwave-assisted condensation 
procedure which cleanly produced rosamines in minutes rather than hours as was the case 
with conventional thermal heating.18  Their significant achievement with microwaves 
could be broadened to other xanthene-based fluorophores, as they also projected. 
 
Scheme 2. The condensation approach to rosamines. 
 
 Secondly, solution-phase organometallic additions to 3,6-diaminoxanthones or 3,6-
diaminochalcogenoxanthones have been heavily utilized for the formation of rosamine 
species described by Detty and co-workers.19,20  Many rosamine analogues have been 
95 
 
synthesized through this method, enabling researchers to investigate their properties in 
photodynamic therapy as newly developed photosensitizers.  For example, the synthesis of 
the first, sulfur-, selenium-, and tellurium-containing rosamine species 19 was reported via 
the key addition of phenylmagnesium bromide (20) to tetramethylchalcogenoxanthones 21 
as shown in Scheme 3. 
 
 
Scheme 3. Synthesis of chalcogenorosamines by Detty.19 
 
 The Burgess group further modified the xanthone framework by incorporating 
cyclic amines 22 through the nucleophilic aromatic substitution reactions of easily 
obtainable 3,6-dihydroxyxanthone ditriflate 23, which were then systematically reacted 
with many arylmagnesium bromides 24 to furnish rosamines 25 in good yields after 
subsequent acid-catalyzed dehydration as outlined in Scheme 4.21 
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Scheme 4. Synthesis of cyclic amine substituted rosamines by Burgess.21 
  
 In 2007, Chang and co-workers16 successfully demonstrated the solid-phase 
synthesis of the first combinatorial library of rosamines, taking advantage of the pivotal 
Grignard addition to resin-bound xanthones.  Their synthesis commenced with the 
construction of 3-amino-6-nitroxanthones 26 through the copper-mediated coupling of 2-
chloro-4-nitrobenzoic acid (27) with 3-acetamidophenol, 3-acetamidothiophenol, and 3-
acetamidoaniline building blocks 28 and the consequent acid-mediated condensations 
under thermal conditions.  After the derivatization of the 3-amino groups of xanthones 26, 
the 6-nitro component was first reduced to a primary amine functionality, which was linked 
to a 2-chlorotrityl resin-support to afford twelve different xanthones 29.  A diverse array 
of 240 rosamine probes 30 were obtained via the two-step successive reactions of 33 
distinct arylmagnesium bromides and the acid-catalyzed dehydration/resin cleavage 
sequence, as shown in Scheme 5. 
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Scheme 5. Combinatorial synthesis of rosamine probes by Chang.16  
 
 Most recently, the Detty22 group demonstrated a novel synthesis of rosamines in a 
third approach, capitalizing on a Suzuki-coupling strategy.  According to this one-pot 
method, chalcogenoxanthones 31 were first treated with triflic anhydride in anhydrous 
acetonitrile to generate the corresponding triflated xanthones 32 in situ in quantitative 
yields.  The triflates 32 were then subsequently reacted with pre-dehydrated boroxin 
species 33 in the presence of catalytic PdCl2(PPh3)2 and quenched with either an aqueous 
solution of HPF6 or HCl to form rosamines 34 in 49-79% isolated yields as shown in 
Scheme 6.  
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Scheme 6. Synthesis of rosamines via Suzuki coupling.22 
 
3.2. Results and Discussion  
 
 Our collaborative multidisciplinary project involved the identification and the 
synthesis of rosamine probes that show low non-specific binding properties and have the 
characteristics of “non-stickiness” which mirrors the balance between intracellular influx 
and efflux activities.23  These are some of the highly preferred properties of fluorescent 
tags in live-cell imaging to gain a high signal/noise ratio for targeted receptors within a 
cell.  A systematic high throughput screening of rosamines was performed to determine 
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molecules that possessed such characteristics in mammalian cells as an early-screening 
method.  The identified compounds in the mammalian system were hypothesized to assist 
the cellular tracking studies in plant and bacterial systems.  Ultimately, the in situ 
proliferation of rhizosphere microorganisms that account for a variety of effects from 
influencing plant growth to human diseases could be examined with the identified probes.24  
 Recently, the Nilsen-Hamilton and Parvin groups utilized Chang’s combinatorial 
rosamine library to screen and quantitatively measure the intracellular influx and efflux 
properties of the fluorescent probes in three different mammalian cancer cell lines, which 
were chosen from both human and mouse samples.  As a result, several hits were 
determined that had the desired property of greater non-stickiness and were subsequently 
validated in plant root hair systems.  Comparison of the uptake and retention values 
measured for each one of the 240-member rosamine library revealed the lead rosamine 
scaffold 35 as the structure as shown in Figure 3.   
 With the lead target in hand, we envisioned a novel synthetic strategy to not only 
access rosamine 35, but also several other rosamine analogues that would have potential 
radiolabelling capability such as rosamine 36 (Figure 3) to provide a multifunctional 
platform for live-cell imaging that is traceable by both fluorescence microscopy and 
autoradiography.25 
 Our synthetic planning began by recognizing a need for a concise route towards a 
primary amine-functionalized rosamine scaffold.  The previous route developed by Chang 
and co-workers16 used 3-nitro-6-aminoxanthone 37.  The 3-nitro moiety of 37 was first 
reduced to the primary amine that was connected to a solid support before the 
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organometallic addition.  Subsequently, the final cleavage of the resin with trifluoroacetic 
acid delivered rosamine 38.   
 
 
Figure 3. Representative structures of the targeted rosamines.  
 
 Even though Chang’s diversity-oriented rosamine synthesis proved very effective 
to generate a large collection of fluorescent library, our solution-phase synthetic design 
was intended to be shorter and scalable for targeted rosamines.  Specifically, capitalizing 
on xanthone 39 which was substituted with a benzophenone imine as the primary amine 
equivalent would allow facile introduction to the highly desirable class of rosamines 38 
though the organometallic addition and the consequential acidic workup as outlined in 
Scheme 7.     
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Scheme 7. Comparison of synthetic strategies to primary amine functionalized rosamines.  
 
 Our synthesis commenced with the preparation of known 3,6-dihydroxyxanthone 
(40) from 2,2′,4,4′-tetrahydroxybenzophenone (41) according to the literature procedure.26  
The suspension of 41 in water was heated to 180 oC in a sealed tube for 72 h to produce 40 
in nearly quantitative yield.  Xanthone 40 was then converted to 3,6-dihydroxyxanthone 
ditriflate 23 by the action of triflic anhydride and pyridine.27  After recrystallization, 
xanthone 23 was isolated in 89% yield.  Subsequently, the transformation of 23 to 
piperidine-substituted xanthone 42 smoothly proceeded, following recent work from the 
Burgess21 lab as shown in Scheme 8.       
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Scheme 8. Synthesis of piperidine substituted xanthone (42)[a].  
[a] Reagents and conditions: a) H2O, 180 oC, 72 h, 98%; b) 40 (1.0 equiv), Tf2O (3.0 equiv), Pyridine (10.0 
equiv), CH2Cl2, 0 oC to 23 oC, 24 h, 89%; c) 23 (1.0 equiv), piperidine (5.0 equiv), DMSO, 23 oC, 1.5 h, 87%. 
 
 We were inspired by the Buchwald28 group’s innovative work of generating aniline 
derivatives from aryl halides and triflates via palladium-catalyzed amination reactions.  
Similarly, we envisioned coupling the readily hydrolyzable and commercially available 
benzophenone imine (43) moiety onto xanthone 42, which, to the best of our knowledge, 
represents the first application of its kind.  The imine that is substituted onto xanthone 44 
would then function as the primary amine equivalent that is essential for our rosamine 
scaffolds in imaging applications.   
 As shown in Scheme 9, the amination of xanthone 42 was carried out in the 
presence of palladium(II) acetate and a catalytic amount of rac-BINAP in dry THF.  The 
imine adduct 44 was cleanly obtained in 84% yield, adapting the conditions developed by 
Buchwald.    
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Scheme 9. Synthesis of xanthone 44 via palladium-catalyzed amination[a]. 
[a] Reagents and conditions: a) 42 (1.0 equiv), 43 (1.2 equiv), Pd(OAc)2 (3 mol %), rac-BINAP (4.5 mol %), 
Cs2CO3 (1.4 equiv), THF, 65 oC, 16 h, 84%. 
 
 Subsequently, the diversification platform 44 was ready for reactions with 
aryllithium building blocks to furnish rosamines.  Our initial studies for the key 
transformation started with the lithiation of tert-butyldimethylsilyl-protected 4′-bromo-
(1,1′-biphenyl)-4-ol 45 and its ensuing reaction with xanthone 44.  After 16 hours of 
stirring at room temperature, the acidification of the reaction mixture with aqueous 
hydrochloric acid formed rosamine 46 as shown in Scheme 10.  TBS deprotection was 
attempted with either tetrabutylammonium fluoride or hydrogen fluoride-pyridine systems 
but was unproductive.  The isolation of rosamine 47 was challenging through 
chromatographic methods because of the charged nature of both the deprotection reagents 
and 47; thus, the synthesis of rosamines using protecting groups was abandoned. 
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Scheme 10. Synthesis of rosamine 47 using TBS-protected aryllithium 45.  
 
  Our second generation attempt to access rosamine 47 featured the in situ generation 
of the dianion from 4′-bromo-(1,1′-biphenyl)-4-ol (48), which rendered the previous  
protecting group unnecessary.  Accordingly, the dianion of 48, formed by the addition of 
two equivalents of n-BuLi, was combined with xanthone 44.  Afterwards, the acid- 
catalyzed hydrolysis of the resulting intermediate pleasingly gave rosamine 47 in 95% 
isolated yield as shown in Scheme 11.  Rosamine 47 is particularly important since it can 
be potentially converted to radiolabelled rosamine 36 (Figure 3) by reacting it with [18F]2-
fluoroethyl arylsulfonates.29  
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Scheme 11. Efficient synthesis of rosamine 47 via the dianion of 48[a]. 
[a] Reagents and conditions: a) 44 (1.0 equiv), 48 (5.0 equiv), n-BuLi (10.0 equiv), THF, -78 oC to 23 oC, 24 
h; b) HCl (2.0 M), 95%. 
 
 Once the conditions were optimized for the aryllithium additions, we looked at a 
few more rosamine analogues that might be useful for imaging applications.  To begin 
with, biphenyls 49-51 were synthesized by the electrophilic substitution of 4′-bromo-(1,1′-
biphenyl)-4-ol (48) with dichloroethane, 1,2-bis(tosyloxy)ethane, and 2-
fluoroethyltosylate, accordingly.  The treatment of biphenyls with a single equivalent of n-
BuLi, efficiently produced aryllithiated species, which were exposed to xanthone 44 to 
construct rosamine analogues 52, 53, and 54 in 78%, 54%, and 82%, respectively, as shown 
in Scheme 12.  Rosamines 52 and 53 are potential candidates for conversion into rosamine 
36 by the fluorine-18 nucleophile.   
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Scheme 12. Synthesis of rosamines 52-54[a,b].  
[a] Reagents and conditions: a) 44 (1.0 equiv), 49-51 (4.0 equiv), n-BuLi (4.0 equiv), THF, -78 oC to 23 oC, 
16 h; b) HCl (2.0 M). [b] 53 was isolated as an inseparable mixture (53:-OTs, 2:1).  
 
3.3. Conclusions 
 
Rosamines have been assembled via three main strategies:  (i) The condensation of 
aminophenols and aryl aldehydes, (ii) the 1,2-addition of aromatic organometallic reagents 
to xanthone carbonyls and the subsequent acid-catalyzed dehydration reaction, as well as 
(iii) Suzuki coupling of triflated xanthones and arylboronic acids.  As part of our 
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collaborative project which set out to synthesize the novel rosamine probes that possess a 
primary amine group on the 3-position and a biphenyl unit on the 9-position of the rosamine 
scaffold, we disclosed an efficient route that allowed a rapid and scalable realization of the 
desired rosamines.  Our synthetic design utilized the benzophenone imine subunit attached 
onto the xanthone framework to mask the amine functionality during the organometallic 
addition and unmask it during the acidic workup, which also assisted in the dehydration 
process towards the formation of fluorescent rosamine dyes.  This newly developed method 
shortened the overall protocol compared to the previous methodologies and provided a 
flexible synthesis of important rosamines analogues for cellular imaging.   
     
3.4. Experimental 
 
General Procedures 
All starting materials were purchased from Sigma-Aldrich or TCI America; 
solvents were purchased from Fisher Scientific and used without further purification.  All 
reactions were carried out in flame-dried glassware under argon with dry solvents under 
anhydrous conditions.  All yields refer to chromatographically isolated products. Reactions 
were monitored by thin-layer chromatography (TLC) carried out on 0.20 mm silica gel 
plates using UV light as a visualizing agent.  Silica gel 60Å, particle size 0.032 – 0.063 
mm, was used for flash column chromatography.  1H and 13C NMR spectra were acquired 
on a Varian MR-400 or Bruker Avance III 600 MHz spectrometer.  1H and 13C chemical 
shifts (δ) are given in ppm relative to the residual protonated solvent peaks (CDCl3: δH = 
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7.26 ppm, δC = 77.0 ppm; CD3OD: δH = 3.31 ppm, δC = 49.0 ppm; (CD3)2SO: δH = 2.50 
ppm, δC = 39.52 ppm) as an internal reference.  High-resolution mass spectra (HRMS) 
were recorded on an Agilent 6540 QTOF (quadrupole time of flight) mass spectrometer 
using ESI (electrospray ionization) or APCI (atmospheric-pressure chemical ionization), 
or EI (electron ionization) on an Agilent 6890 GC/MS.  Melting points are uncorrected and 
were analyzed on a Melt-Temp II capillary melting point apparatus. 
Compounds 2327, 4026, and 4221 were prepared according to literature procedures 
and all obtained NMR data matched the reported values.  Melting points of the rosamines 
47, 52, and 54 could not be accurately determined since the samples decomposed as they 
were monitored up to 300 oC.  
 
Selected Experimental, Physical, and Spectral Data 
 
Xanthone 44.  The title compound was prepared according to the following procedure, 
adapted from Buchwald et al.28  To a flask was added Pd(OAc)2 (10 mg, 0.046 mmol), rac-
BINAP (43 mg, 0.068 mmol), 42 (0.65 g, 1.52 mmol), benzophenone imine (43) (0.33 g, 
1.82 mmol), Cs2CO3 (0.69 g, 2.13 mmol), and THF (10 mL).  The reaction mixture was 
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heated to 65 oC for 16 h, after which it was cooled to room temperature and diluted with 
CH2Cl2 (100 mL).  The reaction mixture was filtered after which it was washed with water 
and brine, dried over sodium sulfate, and concentrated in vacuo.  The crude product was 
purified by flash column chromatography (silica gel, 10% to 25% EtOAc-hexanes) to 
afford 44 (0.70 g, 84% yield) as a yellow solid. 44:  m.p. 180-181 oC; Rf = 0.70 (silica gel, 
EtOAc:hexanes 1:1);  1H NMR (600 MHz, DMSO-d6) δ 7.87 (t, J = 9.2 Hz, 1H), 7.70 (d, J 
= 7.2 Hz, 1H), 7.59 – 7.53 (m, 1H), 7.48 (t, J = 6.9 Hz, 2H), 7.31 (d, J = 6.9 Hz, 2H), 7.23 
(d, J = 6.2 Hz, 1H), 6.96 (d, J = 9.1 Hz, 1H), 6.79 (s, 1H), 6.76 (d, J = 8.7 Hz, 1H), 6.72 
(s, 1H), 3.40 (t, J = 5.0 Hz, 3H), 1.60 – 1.50 (m, 6H) ppm; 13C NMR (150 MHz, DMSO-
d6) δ 173.4, 168.5, 157.7, 156.9, 156.0, 155.0, 138.0, 135.2, 131.5, 129.1, 128.9, 128.7, 
128.4, 128.1, 127.0, 126.2, 117.1, 116.8, 111.5, 111.2, 107.6, 98.6, 47.7, 24.8, 23.9 ppm; 
HRMS (ESI-QTOF) calcd for C31H27N2O2 [M + H]
+ 459.2067, found 459.2057. 
 
 
Biphenyl 49.  To a solution of 4′-bromo-(1,1′-biphenyl)-4-ol (48) (2.00 g, 8.03 mmol) in 
dichloroethane (20 mL) at room temperature was added tetra-n-butylammonium bromide 
(52 mg, 0.16 mmol), followed by 5.0 M NaOH (8.30 mL).  The resulting slurry was heated 
to 85 oC over 16 hours after which the mixture was cooled to room temperature.  The 
solution was diluted with dichloroethane (40 mL), washed with water and brine, dried over 
sodium sulfate, and concentrated in vacuo.  The crude mixture was purified by flash 
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column chromatography (silica gel, 5% to 20% EtOAc-Hexanes) to afford 49 (1.3 g, 52% 
yield) as a white solid.  49:  Rf = 0.85 (silica gel, EtOAc:Hexanes 1:1); 
1H NMR (600 MHz, 
CDCl3) δ 7.54 (d, J = 8.5 Hz, 2H), 7.49 (d, J = 8.7 Hz, 2H), 7.41 (d, J = 8.5 Hz, 2H), 6.99 
(d, J = 8.7 Hz, 2H), 4.28 (t, J = 5.9 Hz, 2H), 3.84 (t, J = 5.9 Hz, 2H) ppm; 13C NMR (150 
MHz, CDCl3) δ 158.0, 139.6, 133.3, 131.8, 128.3, 128.1, 121.0, 115.1, 68.1, 41.8 ppm; 
HRMS (EI-GC/MS) calcd for C14H12BrClO [M+H]
+ 310.9838, found 310.9842. 
 
 
Biphenyl 50.  To a solution of 4′-bromo-(1,1′-biphenyl)-4-ol (48) (1.00 g, 4.01 mmol) in 
acetone (30 mL) was added 1,2-bis(tosyloxy)ethane (2.02 g, 5.46 mmol) and potassium 
carbonate (0.88 g, 6.42 mmol) which was then heated to 55 oC for 24 hours.  After dilution 
with water (30 mL), the reaction mixture was extracted with CH2Cl2 (3 x 30 mL).  The 
combined organic layers were dried over sodium sulfate and concentrated in vacuo.  The 
crude mixture was purified by flash column chromatography (silica gel, 5% to 30% EtOAc-
hexanes) to afford 50 (0.79 g, 44% yield) as a white solid.  50:  Rf = 0.81 (silica gel, 
EtOAc:Hexanes 1:1); 1H NMR (400 MHz, CDCl3) δ 7.83 (d, J = 8.3 Hz, 2H), 7.53 (d, J = 
8.6 Hz, 2H), 7.44 (d, J = 8.9 Hz, 2H), 7.41 – 7.37 (m, 2H), 7.36 – 7.33 (m, 2H), 6.85 (d, J 
= 8.7 Hz, 2H), 4.43 – 4.35 (m, 2H), 4.24 – 4.14 (m, 2H), 2.45 (s, 3H) ppm; 13C NMR (150 
MHz, CDCl3) δ 157.8, 145.0, 139.5, 133.2, 132.9, 131.8, 129.8, 128.3, 128.0, 128.0, 121.0, 
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115.0, 68.0, 65.5, 21.7 ppm; HRMS (APCI-QTOF) calcd for C21H19BrO4S [M+H]
+ 
447.0265, found 447.0264. 
 
 
Biphenyl 51.  To a solution of 4′-bromo-(1,1′-biphenyl)-4-ol (48) (2.00 g, 8.03 mmol) in 
acetone (60 mL) was added 2-fluoroethyltosylate30 (2.45 g, 11.24 mmol) and potassium 
carbonate (1.77 g, 12.85 mmol) which was then heated to 55 oC for 24 hours.  After 
filtration through Celite, the solution diluted with water (30 mL), the reaction mixture was 
extracted with CH2Cl2 (2 x 30 mL).  The combined organic layers washed with brine, dried 
over sodium sulfate and concentrated in vacuo.  The crude mixture was purified by flash 
column chromatography (silica gel, 0% to 10% EtOAc-hexanes) to afford 51 (1.41g, 60% 
yield) as a white solid.  51:  Rf = 0.93 (silica gel, EtOAc:Hexanes 1:1); 
1H NMR (400 MHz, 
CDCl3) δ 7.53 (d, J = 8.5 Hz, 2H), 7.49 (d, J = 8.7 Hz, 2H), 7.41 (d, J = 8.5 Hz, 2H), 7.00 
(d, J = 8.7 Hz, 2H), 4.87 – 4.70 (m, 2H), 4.32 – 4.20 (m, 2H) ppm; 13C NMR (100 MHz, 
CDCl3) δ 158.2, 139.6, 133.1, 131.8, 128.3, 128.0, 120.9, 115.0, 82.7, 81.0, 67.3, 67.1 ppm; 
HRMS (EI-GC/MS) calcd for C14H12BrFO [M+H]
+ 295.0133, found 295.0137. 
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Rosamine 47.  To a solution of 4′-bromo-(1,1′-biphenyl)-4-ol (48) (0.27 g, 1.09 mmol) in 
THF (10 mL) at -78 oC was added n-BuLi (2.5M in hexanes, 0.88 mL, 2.18 mmol), 
dropwise over 5 minutes.  The resulting solution was stirred for 25 minutes during which 
time the consistency resembled a thick slurry.  To this solution was added a cooled solution 
of 44 (0.10 g, 0.22 mmol) in THF (6 mL), dropwise over 5 minutes.  The reaction mixture 
was slowly allowed to warm to room temperature over 24 h, after which 2.0 M HCl (2 mL) 
was added dropwise, during which the color changed from cloudy yellow to red-purple 
upon complete addition of the acid.  The resulting solution was then stirred for 30 minutes 
at room temperature. Utilizing a standard aqueous workup procedure caused product loss 
presumably due to the low solubility of 47 in EtOAc or CH2Cl2.  Therefore, the crude 
solution was directly loaded onto silica gel for purification by flash column 
chromatography (silica gel, 0% to 10% MeOH-CH2Cl2) to afford 47 (100 mg, 95% yield) 
as a purple solid.  47:  Rf = 0.14 (silica gel, MeOH:CH2Cl2 1:9); 
1H NMR (600 MHz, 
CD3OD) δ 7.86 (d, J = 8.1 Hz, 2H), 7.61 (d, J = 8.5 Hz, 2H), 7.50 (d, J = 8.2 Hz, 2H), 7.47 
(d, J = 9.6 Hz, 1H), 7.42 (d, J = 9.2 Hz, 1H), 7.22 (dd, J = 9.7, 2.3 Hz, 1H), 7.13 (d, J = 
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2.3 Hz, 1H), 6.93 (d, J = 8.5 Hz, 2H), 6.87 (dd, J = 9.2, 1.9 Hz, 1H), 6.83 (d, J = 1.9 Hz, 
1H), 3.77 (t, J = 5.4 Hz, 4H), 1.84 – 1.78 (m, 2H), 1.78 – 1.72 (m, 4H) ppm; 13C NMR 
(150 MHz, CD3OD) δ 161.3, 160.1, 159.8, 159.4, 159.2, 158.1, 144.5, 133.6, 133.3, 132.1, 
131.4, 131.3, 129.3, 127.7, 117.9, 117.0, 115.9, 114.9, 114.5, 98.6, 98.2, 49.9, 27.1, 25.3 
ppm; HRMS (ESI-QTOF) calcd for C30H27N2O2 [M - Cl]
+ 446.1994, found 447.2065. 
 
 
Rosamine 52.  To a solution of 49 (0.28 g, 0.89 mmol) in THF (10 mL) at -78 oC was 
added n-BuLi (2.5M in hexanes, 0.35 mL, 0.89 mmol), dropwise over 5 minutes.  The 
resulting solution was stirred for 30 minutes after which a cooled solution of 44 (0.10 g, 
0.22 mmol) in THF (5 mL) was added dropwise over 5 minutes.  The reaction mixture was 
slowly allowed to warm to room temperature over 16 h, after which 2.0 M HCl (2 mL) was 
added dropwise, during which the color changed from cloudy yellow to red-purple upon 
complete addition of the acid.  The resulting solution was then stirred for 30 minutes at 
room temperature.  The solution was diluted with EtOAc (100 mL), washed with water (2 
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x 10 mL), and dried over sodium sulfate (utilizing magnesium sulfate caused product loss) 
and concentrated in vacuo. The crude mixture was purified by flash column 
chromatography (silica gel, 2% to 10% MeOH-CH2Cl2) to afford 52 (93 mg, 78% yield) 
as a purple solid.  52:  Rf = 0.15 (silica gel, MeOH:CH2Cl2 1:9); 
1H NMR (400 MHz, 
CDCl3) δ 8.38 (s, 2H), 7.76 (d, J = 8.1 Hz, 2H), 7.64 (d, J = 8.7 Hz, 2H), 7.47 – 7.33 (m, 
3H), 7.30 (d, J = 2.4 Hz, 2H), 7.16 (d, J = 9.3 Hz, 1H), 7.06 (d, J = 8.7 Hz, 2H), 6.93 (dd, 
J = 9.6, 2.1 Hz, 1H), 6.85 (d, J = 2.2 Hz, 1H), 4.32 (t, J = 5.8 Hz, 2H), 3.87 (t, J = 5.8 Hz, 
2H), 3.64 (s, 4H), 1.77 (s, 6H) ppm; 13C NMR (150 MHz, CDCl3) δ 160.7, 158.5, 158.4, 
157.7, 156.7, 155.8, 142.6, 132.8, 131.9, 131.6, 130.3, 130.1, 128.4, 126.9, 118.9, 115.3, 
114.4, 113.6, 112.6, 98.9, 97.7, 68.2, 48.7, 41.9, 25.7, 24.2 ppm; HRMS (ESI-QTOF) calcd 
for C32H30ClN2O2 [M - Cl]
+ 509.1996, found 509.2002. 
 
 
Rosamine 53.  To a solution of 50 (0.40 g, 0.89 mmol) in THF (10 mL) at -78 oC was 
added n-BuLi (2.5M in hexanes, 0.35 mL, 0.89 mmol), dropwise over 5 minutes.  The 
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resulting solution was stirred for 30 minutes, after which a cooled solution of 44 (0.10 g, 
0.22 mmol) in THF (10 mL) was added dropwise over 5 minutes.  The reaction mixture 
was slowly allowed to warm to room temperature over 16 h, after which 2.0 M HCl (2 mL) 
was added dropwise, during which the color changed from cloudy yellow to red-purple 
upon complete addition of the acid.  The resulting solution was then stirred for 30 minutes 
at room temperature.  The solution was diluted with CH2Cl2 (100 mL), washed with water 
(2 x 10 mL), and dried over sodium sulfate and concentrated in vacuo.  The crude mixture 
was purified by flash column chromatography (silica gel, 2% to 10% MeOH-CH2Cl2) to 
afford purple solid 53 (87 mg, ca. 54% yield) as an inseparable 2:1 mixture of 53 to tosylate 
impurity (based on 1H NMR analysis).  53:  Rf = 0.29 (silica gel, MeOH:DCM 1:9); 
1H 
NMR (600 MHz, CDCl3) δ 8.30 (s, 2H), 7.87 (d, J = 7.8 Hz, 1H, CHx2 on -OTs), 7.83 (d, 
J = 7.8 Hz, 2H), 7.69 (d, J = 7.8 Hz, 2H), 7.56 (d, J = 8.1 Hz, 2H), 7.36 (d, J = 7.8 Hz, 2H), 
7.32 – 7.27 (m, 2H and 1H, CHx2 on -OTs), 7.16 – 7.12 (m, 3H), 7.10 (d, J = 7.8 Hz, 1H), 
6.91 (d, J = 8.4 Hz, 2H), 6.75 (s, 1H), 4.40 (t, J = 4.6 Hz, 2H), 4.22 (t, J = 4.5 Hz, 2H), 
3.60 (s, 4H), 2.45 (s, 3H), 2.27 (s, 1.5H, CH3 on 
-OTs), 1.71 (d, J = 23.5 Hz, 6H) ppm; 13C 
NMR (150 MHz, CDCl3) δ 160.7, 158.3, 158.3, 157.6, 156.4, 155.7, 145.0, 143.6 (2C on -
OTs), 142.5, 139.0 (2C on -OTs), 132.8, 132.7, 131.8, 131.5, 130.2 (2C on -OTs), 130.1, 
129.9, 128.5, 128.3, 128.0, 126.9, 126.1 (2C on -OTs), 118.9, 115.1, 114.2, 113.6, 112.5, 
98.9, 97.6, 68.1, 65.6, 48.7, 25.7, 24.1, 21.7, 21.3 (C on -OTs) ppm; HRMS (ESI-QTOF) 
calcd for C39H37N2O5S [M - Cl]
+ 645.2418, found 645.2417. 
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Rosamine 54.  To a solution of 51 (0.26 g, 0.89 mmol) in THF (10 mL) at -78 oC was 
added n-BuLi (2.5M in hexanes, 0.35 mL, 0.89 mmol), dropwise over 5 minutes.  The 
resulting solution was stirred for 30 minutes, after which a cooled solution of 44 (0.10 g, 
0.22 mmol) in THF (5 mL) was added dropwise over 5 minutes.  The reaction mixture was 
slowly allowed to warm to room temperature over 16 h, after which 2.0 M HCl (2 mL) was 
added dropwise, during which the color changed from cloudy yellow to red-purple upon 
complete addition of the acid.  The resulting solution was then stirred for 30 minutes at 
room temperature.  The solution was diluted with CH2Cl2 (100 mL), washed with water (2 
x 10 mL), brine (10 mL), dried over sodium sulfate and concentrated in vacuo.  The crude 
mixture was purified by flash column chromatography (silica gel, 2% to 10% MeOH- 
CH2Cl2) to afford 54 (94 mg, 82% yield) as a purple solid.  54:  Rf = 0.12 (silica gel, MeOH: 
CH2Cl2 1:9); 
1H NMR (600 MHz, CD3OD) δ 7.88 (d, J = 7.5 Hz, 2H), 7.71 (d, J = 7.8 Hz, 
2H), 7.50 (d, J = 7.5 Hz, 2H), 7.44 (d, J = 9.5 Hz, 1H), 7.39 (d, J = 9.0 Hz, 1H), 7.21 (d, J 
= 9.2 Hz, 1H), 7.10 (d, J = 8.8 Hz, 3H), 6.87 (d, J = 9.2 Hz, 1H), 6.82 (s, 1H), 4.77 (d, J = 
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45.3 Hz, 2H), 4.30 (d, J = 28.8 Hz, 2H), 3.76 (s, 4H), 1.84 – 1.70 (m, 6H) ppm; 13C NMR 
(150 MHz, CD3OD) δ 161.3, 160.4, 160.0, 159.7, 159.2, 158.0, 144.1, 133.8, 133.6, 133.2, 
131.6, 131.5, 129.3, 127.9, 117.9, 116.3, 115.9, 114.9, 114.4, 98.7, 98.2, 82.6, 82.6, 68.8, 
68.7, 49.9, 27.1, 25.3 ppm; HRMS (ESI-QTOF) calcd for C32H30FN2O2 [M - Cl]
+ 
493.2291, found 493.2290. 
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CHAPTER 4. 
GENERAL CONCLUSIONS 
 
In the first chapter of this dissertation the total synthesis of (±)-paracaseolide A was 
described.  The naturally-occurring meroterpenoid was constructed via a series of synthetic 
manipulations featuring the introduction of phenylsulfenyl groups to the symmetrical bis-
lactone moiety.  The resultant intermediate was then desymmetrized via the controlled 
single-sulfide oxidation and elimination, followed by the key tandem 1,4-addition/aldol 
reaction to introduce the alkyl and alkenyl subunits of the natural scaffold.  Subsequently, 
the final sulfoxide elimination provided (±)-paracaseolide A in 8 steps and 6.6% overall 
yield.  Upon comparison of this work against the other methods reported in the literature, 
our method offers strong potential for the diverse functionalization of analogues to enhance 
the already displayed anti-cancer activity.   
The second chapter outlined the first inverse electron-demand Diels–Alder 
(IEDDA) reaction between 3-chloroindoles and methyl coumalate to form carbazole 
alkaloids.  The novel methodology delivered natural and synthetic carbazole scaffolds 
through the one-pot IEDDA/decarboxylation/aromatization cascade in a regioselective 
manner in up to 90% yield.  Investigation of the scope and limitations of the present 
methodology revealed that the electron-rich indoles provided high yields of the 
corresponding carbazoles, whereas highly electron poor indoles did not proceed though the 
reaction cascade as expected.   
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The final chapter disclosed the details of an efficient synthesis of rosamine probes 
that possess a primary amine group for applications in cellular imaging.  The synthetic 
methodology took advantage of the benzophenone imine moiety which was substituted on 
the xanthone scaffold during the organometallic addition.  Ensuing acidic workup not only 
unmasked the primary amine group but also facilitated the formation of highly conjugated 
rosamines via the final dehydration of the intermediate. Overall, the newly developed 
method rapidly furnished fluorescent rosamines that also have radiolabelling capability 
upon treatment of either [18F]2-fluoroethyl arylsulfonates or a fluorine-18 nucleophile. 
 
 
 
